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Abstract 
One of the most common manifestations of dopaminergic degeneration in humans is in 
Parkinson’s Disease (PD). Although dopaminergic degeneration affects a significant 
portion of the aging population, the pathways and mechanisms underlying it have not 
yet been elucidated.  
 
The Doitsidou lab has recently established a model of dopaminergic degeneration in 
Caenorhabditis elegans. In this model, a Transient Receptor Potential (TRP) channel 
(TRP-4) has mutated and results in a gain of function. Based on the morphology of the 
dopaminergic neurons, the overactive channel is believed to be activating a necrotic cell 
death pathway.  
This thesis aims to identify the pathways relevant to TRP-4 mediated dopaminergic de-
generation in Caenorhabditis elegans. It takes a two-pronged approach, comparing 
TRP-4 degeneration to other models of neurodegeneration and conducting a forward 
genetic screen to identify novel candidates.  
 
Through these approaches, the nature of TRP-4 degeneration has been further eluci-
dated. The results gathered in this thesis explore the involvement of lysosomal acidifica-
tion through the V-ATPase pump in dopaminergic cell death and are not conclusive as 
to whether or not the V-ATPase pump plays a role in TRP-4 induced degeneration. The 
lysosomal biogenesis pathway is implicated in dopaminergic degeneration in the TRP-4 
model. Differences in lysosomal morphology in dopaminergic neurons are established 
between the wild type and degenerating states. Finally, three full and three partial sup-
pressors of degeneration were discovered through the automated forward genetic 
screen. Together, this thesis brings insight into intracellular the mechanisms underlying 
a novel, TRP-channel based model of dopaminergic degeneration. 
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Acronyms  
Acronym Meaning 
ADE  Anterior deirid 
ASP Aspartyl 
ATP  Adenosine triphosphate 
bp Base pairs 
CALB calbindin 
cDNA  complementary deoxyribonucleic acid 
CEPD  dorsal cephalic 
CEPV  ventral cephalic 
CLP calpain 
CMA  chaperone-mediated autophagy 
CNX calnexin 
CRT calreticulin 
CSP caspase 
DA  dopaminergic 
DAT dopamine transporter 
DEG/ENaC degenerin/epithelial sodium channel 
DNA  deoxyribonucleic acid 
ds Double stranded 
EGL egg laying defect 
EGTA  ethylene glycol tetra acetic acid 
EMS Ethyl methanesulfonate 
ER endoplasmic reticulum 
F Forward 
F1 First filial generation 
F2 Second filial generation 
F3 Third filial generation 
GBA Glucocerebrosidae 
GD Gaucher’s Disease 
GFP  green fluorescent protein 
GLO Gut granule loss 
GoF  gain of function 
GoI Gene of interest 
HS heat shock 
iPS Induced pluripotent stem cell 
LB Lewy body 
LG Linkage group 
LMP Lysosome membrane protein 
LoF  loss of function 
LRO Lysosome related organelle 
NCBI National Center for Biotechnology Information 
NCCD  Nomenclature Committee on Cell Death 
NGM Nematode growth medium 
NPG  Nature publishing group 
P0 Parental generation 
PCD  programmed cell death 
PCR Polymerase chain reaction 
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PD  Parkinson’s Disease 
PDE  posterior deirid 
R reverse 
RNA  ribonucleic acid 
RNAi  ribonucleic acid interference 
ROS reactive oxygen species 
RT Room temperature 
SEM Standard error of means 
SN  substantia nigra 
SNCA  synuclein 
TRP  transient receptor potential 
UNC uncoordinated 
V-ATPase vacuolar H+ ATPase 
WGS Whole genome sequencing 
WT Wild type 
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Introduction 
A model of neurodegeneration: TRP-4 
In an automated forward genetic screen in Caenorhabditis elegans for mutants 
involved in dopaminergic specification (Doitsidou et al., 2008), the trp-4(ot337) or 
trp-4(d) mutant was discovered. This mutant has a full set of DA neurons embry-
onically and fewer than normal in adulthood (Nagarajan et al., 2014). Using 
whole genome sequencing (WGS) and bioinformatics analysis software the re-
sponsible mutation was identified. The progressively degenerating mutant had an 
M1779I1 amino acid substation mutation in the gene encoding TRP-4 (Nagarajan 
et al., 2014).  
TRP-4 is part of the Transient Receptor Potential channel superfamily. It is the 
sole TRPN member in C. elegans. The TRP proteins are involved in sensation, 
including vision, taste, olfaction, hearing, touch, and thermo-and osmosensation. 
While TRPN members are pre-
sent across much of phylogeny, 
they are not conserved in mam-
mals- although there are at least 
twenty eight different TRP mem-
bers found in mammals 
(Venkatachalam and Montell, 
2007). TRP-4 coordinates as a 
pore-forming subunit of the 
mechanotransduction channel in 
DA neurons (Kang et al., 2010). 
Structurally, TRP-4 is a protein 
composed of: four ankyrin re-
1 G13503A is the nucleotide substitution 
 
Figure 1 The TRPN channel in C. elegans is com-
posed of six transmembrane segments. The amino 
and carboxy terminals are both intracellularly located. 
Cations, including Ca++ and Na+, enter through a 
channel located between the fifth and sixth trans-
membrane segments. Four ankyrin repeats (green 
boxes) are located at the amino terminal. Figure 
adapted from (Nagarajan et al., 2014). 
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peats at the amino terminal, six transmembrane segments, a cation permeable 
channel between the fifth and sixth segments, and intracellular amino and car-
boxy terminals (Figure 1) (Nagarajan et al., 2014). 
Phenotypically, trp-4 null animals exhibit locomotion defects, including exagger-
ated bending and a distinct body posture, which suggest a stretch receptor role 
for the channel (Li et al., 2006). In trp-4 loss -of-function mutants, there is no ob-
served effect on dopaminergic neuron survival. In trp-4(d) mutants, there is a loss 
of the majority of dopaminergic neurons, suggesting that these mutants carry a 
gain-of-function mutation. Moreover, in trp-4(d) mutants the dopaminergically de-
pendent basal slowing response behavior is lost even in worms with surviving 
dopaminergic neurons; which suggests that the mutation interferes with channel 
function (Nagarajan et al., 2014).  
 As the null mutant does not show DA degeneration, the dominant mutation in the 
trp-4 locus was shown to be responsible for the degeneration phenotype through 
recapitulation2 experiments (Nagarajan et al., 2014). trp-4(d) is expressed in the 
DA neurons, the DVA and DVC neurons (Li et al., 2006), and fourteen additional 
head neurons (Nagarajan et al., 2014). While a wild-type worm has eight DA 
neurons Figure 2, the phenotype of an adult trp-4(d) worm is severely degener-
ating CEPs, mildly degenerating ADEs, and non-degenerating PDEs (Nagarajan 
et al., 2014). 
2 There were two proof of principle experiments: 1) a reversion of phenotype screen and 2) trp-
4(ot337) cDNA introduction into the WT.  
 
Figure 2 The DA neurons of C. elegans are shown here. There are two of each class: CEPVs (purple 
arrows), CEPDs (blue arrows), ADEs (yellow arrows), and PDEs (red arrows). The animal is shown from left 
to right: posterior to anterior. DA neurons are marked with a DAT-1::GFP reporter. Image credit: Maria 
Doitsidou. 
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Involvement of Calcium  
TRP channels are known to conduct monovalent and divalent cations such as 
Na+ and Ca++ (Venkatachalam and Montell, 2007) and known to be involved with 
intracellular Ca++ homeostasis (Gees et al., 2012). Ca++ dyshomeostasis is one of 
the key events in a supposed necrotic cell death pathway (Golstein and Kroemer, 
2007) and is implicated in a range of neurodegenerative diseases (Galluzzi et al., 
2012). 
The trp-4(d) channel’s relationship to Ca++ homeostasis has been genetically and 
pharmacologically explored. When trp-4(d) mutants are exposed to calcium-
chelating factors, such as the chemical EGTA or when calbindin (calcium-binding 
protein) is expressed in the dopamine neurons of these mutants, degeneration is 
suppressed. trp-4(d) has also been crossed with calreticulin, a Ca++ binding ER 
chaperone, and consequently showed significant decrease of degeneration. ER 
Ca++ exit has been blocked with dantrolene and again suppression was observed 
(Nagarajan et al., 2014). Thus, Ca++ homeostasis was previously shown to be a 
key contributor to DA degeneration in the trp-4(d) model. 
Mode of cell death  
 Determining the mode of cell death at play in trp-4(d) induced degeneration is 
not a facile task. While there is an established canonical apoptotic pathway, no 
such certainty exists for necrosis. Although morphological data alone is no basis 
for conclusion, it does provide a key 
insight into the mode of cell death. 
trp-4(d) degeneration is seen in Fig-
ure 3 and exhibits characteristic 
rounded necrotic morphology 
(Nagarajan et al., 2014). 
Previously, in order to ascertain 
whether or not the death occurring in 
the trp-4(d) model was apoptotic, var-
 
Figure 3 trp-4(d) degeneration in a DA neu-
ron. While neurons are typically elongated, the 
DA neuron here is uncharacteristically rounded 
in shape. From Figure 3 in (Nagarajan et al., 
2014) . 
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ious factors in the well-established apoptotic pathway in C. elegans (Pathway 1) 
were genetically explored.  Specifically, the executioners of apoptosis ced-3 and 
ced-4 have been tested in the trp-4(d) model and were all found not to be in-
volved. Additionally, non-canonical apoptosis C. elegans caspases (csp-1, csp-2, 
csp-3)3 were tested and also found to be dispensable to the trp-4(d) model of cell 
death (Bachelor’s Thesis, Strenitz, 2014) (Nagarajan et al., 2014). 
 
Great strides have been taken to determine the identity of a necrotic pathway; 
this too is on its way to being defined with the help of the model nematode. Stud-
ies from the Tavernarakis and Driscoll labs have pioneered the exploration of ne-
crotic mechanisms in C. elegans. Though necrosis has no defined pathway or 
classical understanding like apoptosis, thanks to the work done in these and oth-
er labs there are several events associated with necrosis.  These events include: 
Ca++ dyshomeostasis, requirement of calpains and cathepsins, and lysosomal 
alteration (Golstein and Kroemer, 2007). Despite this, the list of necrotic events is 
not definitive and a canonical necrotic pathway is still open for further characteri-
zation. 
 A key event in proposed necrotic pathways is the activation of aspartyl and cal-
pain proteases (Figure 4). Syntichaki et al. proved their necessity for death in the 
mec-4(d) model (Syntichaki et al., 2002). Calpain4 and aspartyl proteases were 
tested in this lab with single-gene knockdowns for involvement in trp-4(d) cell 
death and found to be uninvolved. The aspartyl proteases ASP-1, ASP-3, ASP-45, 
and ASP-5 were tested with RNAi experiments and similarly showed no effect 
(Bachelor’s Thesis, Maugard, 2013). However, it is possible that redundancy is-
3 It should be noted that for ced-9, csp-1, csp-2, and csp-3 there was an insufficient sampling of 
the population (<50 individuals). However, general trends were established that can be consid-
ered in the context of the remaining significant results. 
4 With crossing (clp-2, clp-4, clp-6, and clp-7) and RNAi (CLP-1, CLP-4, and TRA-3).  
5 Recently crossed and again found to be irrelevant.  
  Pathway 1 egl-1 –ı ced-9 –ı ced-4 → ced-3 
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sues might be responsible for the absence of observed effects of these cases on 
the dopaminergic degeneration in the trp-4(d) model. 
 Although calpain and aspartyl proteas-
es have not yet been implicated in trp-
4(d) degeneration, the necrotic mor-
phology, in combination with the partial 
suppression of degeneration in calretic-
ulin loss of function mutants, points to a 
necrotic mechanism. 
One recent series of experiments has 
identified that autophagic mechanisms 
are involved in trp-4(d). UNC-51 acti-
vates vesicle nucleation and conse-
quently formation of the phagophore, an 
important initiation step for autophagy. 
unc-51 alleles and also atg-18 alleles (a molecular player important for protein 
retrieval step in autophagy) were found to significantly suppress DA degeneration 
in trp-4(d) (Bachelor’s Thesis, Håland, 2014).  
While the autophagy results do not offer a conclusive death pathway, they do im-
plicate an intriguing player: the lysosome. The autophagosome eventually fuses 
with the lysosome, thus implicating the lysosome as a downstream player in the 
trp-4(d) cell death pathway. 
Structure and aim of the thesis 
The aim of this thesis is to assess the role and molecular pathways that mediate 
dopaminergic cell death in the trp-4 (ot337) model. To tackle this question, a two-
pronged approach has been taken; the first prong of which is the classical ‘’can-
didate’’ approach. The candidate approach is often used in genetic studies and 
involves picking a handful of molecular targets, ‘’candidates,’’ that have been 
 
Figure 4 The Calpain/Aspartyl pathway in 
necrosis is shown here. Calcium ions acti-
vate calpain proteases, which normally 
cleave aspartyl proteases at cysteine, and 
abnormally rupture the lysosomal membrane. 
The aspartyl proteases activate cathepsins. 
Aspartyl proteases are also notably activated 
by a decrease in pH, driven by V-ATPase 
acidification.   
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previously shown to be instrumental in the same or comparable pathway. The 
second prong of the thesis utilizes an ‘’unbiased’’ approach and results in the 
identification of novel players. The approach is unbiased in that it does not antici-
pate a molecular player, but rather isolates one phenotypically through a genetic 
screen and then identifies it. trp-4 (ot337) itself was isolated and identified as part 
of a screen for dopaminergic fate.  
Candidate Approach 
The candidate chosen for this thesis have all been previously identified to be in-
volved in the mec-4(d) model of necrotic cell death. MEC-4 is an overactive de-
generin/epithelial sodium channel (DEG/ENaC). The mutated version causes se-
vere and early degeneration of mechanosensory neurons. The channel was dis-
covered by Driscoll and Chalfie and is part of the degenerin gene family, which is 
conserved across phylogeny (Driscoll and Chalfie, 1991) (Hong and Driscoll, 
1994). It conducts excessive sodium and calcium into neurons and its actions 
can be suppressed by preventing release of Ca++ from ER channels or storage of 
Ca++ within the ER, such as in calreticulin mutants (Bianchi et al., 2004) (Xu et al., 
2001). Previous studies exploring neuroprotective factors in mec-4(d) induced 
neurodegeneration have implicated several necessary agents for the necrotic 
pathway, among them: the vacuolar H+ -ATPase (V-ATPase) pump, the hormeo-
tic protection of moderate heat shock, and the biogenesis of the lysosome. In this 
thesis, we explored these neuroprotective factors for their ability to ameliorate 
trp-4(d) dopaminergic degeneration. The candidate pathways that will be ex-
plored in this thesis are graphically summarized in Figure 5. 
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Figure 5 Pathways explored during the Candidate Approach includes various strategies 
aimed at identifying the pathways that mediate trp-4(d) induced degeneration.. The entire illustra-
tion is of a generalized C. elegans dopaminergic neuron. A shows the trp-4 channel, with trans-
membrane domains and intracellular amino and carboxy terminals. Figure adapted from 
(Nagarajan et al., 2014). B shows the V-ATPase pump present on the lysosomal membrane with 
protons entering into the cell through the pump and activating the release of the cathepsins. (In 
the grey box rests a pathway –not tested in this thesis- in which Ca++ activated calpains rupture 
the lysosome, unleashing the aspartyl proteases and ultimately lead to cell death). C illustrates 
the Golgi body with internal Ca++ stores. With Ca++ being buffered by the Golgi after precondition-
ing (HS thunderbolt in the schematic), the cell may be more resilient even with excitotoxic influx of 
Ca++ (A). D depicts lysosomal biogenesis.  
D 
C 
B 
A 
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Vacuolar H+ ATPase Pump 
This thesis primarily focuses on the in-
volvement of the lysosome in the trp-
4(d) model of degeneration. Lysosomal 
acidification is a key event in previously 
described necrotic pathways (Artal-
Sanz et al., 2006) To test the acidifica-
tion theory this thesis explores, in the 
context of trp-4(d) model, the role of the 
V-ATPase pump, a factor in lysosomal 
and cellular pH (Syntichaki et al., 2005).  
The V-ATPase pump (Figure 6) that 
rests on the membrane of organelles is 
responsible for the acidification of the 
lysosome at the cost of one molecule of 
ATP. ATP is hydrolyzed to ADP by the 
major B subunit of the pump, controlled 
by genes vha-12 and spe-5. The D sub-
unit twists to begin the mechanism of 
lysosomal acidification. Ultimately, the c and c+ subunits will direct the flow of pro-
tons into the lumen of the lysosome. The pump is functional in acidification of 
synaptic vesicles, regulation of neurotransmitter release, embryogenesis, zygotic 
morphogenesis, and apoptotic- corpse clearance (Ernstrom et al., 2012).  
Additionally, the V-ATPase pump has been implicated in necrosis. vha-2, vha-10, 
and vha-12 were tested in mec-4(d) mutants and were found to ameliorate cell 
death in the six C. elegans mechanosensory neurons. vha-12 showed the 
strongest suppression of all (84%) when mutated in the mec-4(d) mutant6. Lyso-
6 Mec-4(d) had about 220/600 vacuolated cells and mec-4(d);vha-12(n2915) had about 90/600 
vacuolated cells, Figure 1A in Syntichaki, P., Samara, C. and Tavernarakis, N. (2005) 'The 
vacuolar H+ -ATPase mediates intracellular acidification required for neurodegeneration in C. 
elegans', Curr Biol, 15(13), pp. 1249-54. 
 
Figure 6 The V-ATPase pump sits on the 
membrane of organelles. It consists of two 
sectors: V1 and V0. The V1 sector is mem-
brane bound and contains the major B subu-
nit. The V0 sector is cytoplasmically located 
and regulates the flow of protons into the lu-
men of the lysosome. Blue and yellow boxes 
are indicative of experiments performed for 
this thesis. Figure is adapted from (Ernstrom 
et al., 2012). 
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somal acidification is crucial to the necrotic mechanism. Sharp decrease of the 
acid-base balance in the lysosome triggers aspartyl7 proteases to release diges-
tive cathepsin enzymes into the cell. Cellular acidification is regulated by the V-
ATPase pump and it has been suggested that necrotic cells demonstrate a lower 
cytoplasmic pH (Syntichaki et al., 2005) (Syntichaki and Tavernarakis, 2003).  
The involvement of the V-ATPase pump in dopaminergic degeneration was test-
ed in this thesis genetically with crosses (blue boxes in Figure 6) and RNAi (yel-
low boxes in Figure 6), and pharmacologically with the bafilomycin chemical.  
Lysosomal biogenesis 
Lysosomal biogenesis refers to the generation of new lysosomes in the cell. 
Pathways that transport lysosomal membrane proteins and pathways that 
transport hydrolases to the lysosome are both considered part of lysosomal bio-
genesis. As the lysosome is the ultimate site of all cellular degradation, it is in-
herently a suspect in cell death pathways. Indeed, lysosome morphology was 
previously shown to be altered during necrotic cell death and lysosomal biogene-
sis was found to contribute to mec-4(d) induced necrosis (Artal-Sanz et al., 2006).   
In order to morphologically assess the effect of Trp-4(d) channel on lysosomal 
morphology, a lysosomal associated membrane GFP fusion protein (LMP-
1::GFP) under the dopaminergic DAT-1 promoter was cloned and subsequently 
injected into trp-4(ot337) animals (Figure 5D). By comparing the LMP-1::GFP in 
mutant and wild-type animals, morphological observations concerning the con-
sequences of trp-4(d) mutation on lysosomal morphology. 
In C. elegans, a Rab GTPase called GLO-1 is required for the biogenesis of ly-
sosome related organelles (LRO) called gut granules. They are known to be in 
the gut (Hermann et al., 2005), but their presence has not been determined in the 
DA neurons. They are typically larger than lysosomes and are thought to be a 
storage related organelle; particularly zinc storage (Coburn and Gems, 2013). glo 
mutants were shown to be defective in lysosomal biogenesis and their absence 
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has been shown to be a protective effect in mechanosensory neurons in the 
mec-4(d) model. (Artal-Sanz et al., 2006).  
Since lysosomal morphology and biogenesis were affected in the mec-4(d) mu-
tant, these two points will be tested in this thesis. Morphology will be explored 
with the use of a lysosomal reporter and biogenesis with genetic candidates.  
Heat shock preconditioning 
One pathway that was shown to be relevant in preventing several types of ne-
crotic cell death involves heat shock preconditioning. Preconditioning is a kind of 
adaptation. Stress can happen in extreme amounts, such as the kind caused by 
trp-4(d) channels, or in small amounts. It has been shown that small and slow 
exposure to stress may better prepare a system for larger onslaughts (Calabrese, 
2004). 
Stressors are diverse and can take various forms including heat and hypoxia. By 
exposing C. elegans to extreme and less extreme heat, one can test the hormetic 
theory. This was indeed previously employed in the case of necrotic cell death, 
and it was observed that heat shock induced necrosis was limited after moderate 
heat preconditioning. Furthermore, preconditioning had a protective effect in both 
the mec-4(d) model and a PD α-synuclein model  of cell death. This suggests 
that the protection provided by the heat-shock-response pathway is wide-ranging 
and not exclusive to one type of stressor (Kourtis et al., 2012).  
In the mec-4(d) model it was shown how preconditioning affected a cell undergo-
ing necrotic insults: It sequestered cytoplasmic Ca++ increase caused by necrotic 
insults by increasing Ca++ uptake by the Golgi apparatus. (Kourtis et al., 2012).In 
this thesis, similar experiments were conducted to see what effect precondition-
ing has on trp-4(d) induced damage (Figure 5C).  
Unbiased approach 
C. elegans is an excellent organism to perform forward genetic screens with be-
cause of its versatility (Tucci et al., 2011). Suppressors for mec-4(d) induced de-
generation were discovered through this kind of screen (Xu et al., 2001). While in 
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the mec-4 screen, worm coordination was used as a selecting factor, for this the-
sis, GFP brightness was the selecting factor. The same method and approach 
were taken in a screen conducted in the Hobert lab for dopaminergic specifica-
tion (Doitsidou et al., 2008). It was during this screen that two trp-4 mutant alleles 
were discovered, one of which was ot337, the gain-of-function allele used for this 
thesis . 
A previous trp-4(d) suppressor screen in the Doitsidou lab, yielded many intra-
genic suppressors. In this thesis, a strain with two copies of trp-4(ot337), one en-
dogenous and one engineered into the C. elegans genome is used. In order to 
discover novel factors in trp-4(d) pathways, a forward genetic screen was per-
formed on this newly engineered screening strain.  
 
In summary, by way of the trp-4(d) model, this thesis aims to address both mor-
phological and biochemical aspects of cell death. This is to be done with a two-
pronged approach: candidate and unbiased. trp-4 is remarkable for the fact that it 
is a progressive and robust death model. Though models will always be imper-
fect, the trp-4 mutant allows us an entry point into a novel understanding of do-
paminergic degeneration. 
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Theory 
Parkinson’s and Dopaminergic Degeneration 
An historic overview  
In 1817, in An Essay on the Shaking Palsy, James Parkinson detailed the mani-
festation of paralysis agitans in his patients, as well as in random passersby on 
the street. So characteristic is the disorder that three out of six described cases 
were purely observational and took place at a distance. Today, mostly in honor of 
his thoroughness of description and of his efforts to make a unifying definition of 
the disease, paralysis agitans is known as Parkinson’s Disease (PD) (Parkinson, 
1817).  
In 1919, proof arose for the origins of PD that separated it from other brain disor-
ders. It was in that year that Konstantin Tretiakoff defended his thesis8 at the 
University of Paris. In his examination of the substantia nigras (SN) (blue box and 
line in Figure 7) of nine brains from patients suffering paralysis agitans, Tre-
tiakoff noticed a, ‘’marked loss of the pigmented nigral neurons with swelling of 
cell bodies, [granular] degeneration and neurofibrillary alterations.’’ Tretiakoff no-
ticed another irregularity in the SNs of the affected brains and named them 
‘’corps de Lewy,’’ or, Lewy bodies (LBs). Even today, the identification of LBs in 
the SN of patients is a key diagnostic tool for clinicians.  Tretiakoff observed 
these findings in not only Parkinsonism cases, but also other disorders in which 
muscular tone was affected9 and they were further supported with more brain 
dissections. 
 
8 A Study of the Pathological anatomy of the locus niger of Soemerring and its relevance to the 
pathogenesis of changes in muscular tone in Parkinson’s Disease. NB: the locus niger of 
Soemerring is the substantia nigra. 
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The thesis did not spur scientific exploration 
into the curious loss of pigmented neurons from 
the SN and the appearance of the strange LBs. 
Yet, this should not be surprising, as the SN is 
not the only affected brain region in PD. 
Though it is the first hit, the loss of neurons 
there will cause a denervation in the regions 
that the projections normally reach. The gen-
eral pathways of these projections are shown in 
Figure 7. Though it was Tretiakoff that identi-
fied the LBs in the SN and the loss of pigment-
ed neurons from the SN (also confirmed by 
Hassler in 1938), it would take some more sci-
entists and decades to identify what those pig-
mented neurons were and why their loss was 
so devastating. 
The SN is a relatively easy area of the brain to 
identify, due to the pigmented neuromelanin10 containing dopaminergic neurons 
(Fedorow, Tribl et al. 2005). The distribution of dopamine in the dog brain was 
demonstrated by Bertler and Rosengren in 1959; weeks later, also shown by 
Sano in the human brain. It was Hornykiewicz that uncovered the loss of DA neu-
rons from the substantia nigra, when he characterized dopamine in Parkinsoni-
an11 brains (Fedorow et al., 2005). With these discoveries, the pathological un-
derstanding of PD was extended, and its treatment became a reality with the 
administration of L-Dopa. However, what remained to be understood was why 
the DA cells were dying in the first place.  
10 Neuromelanin is thought to be a byproduct of oxidative polymerization of both the catecholines 
dopamine and noradrenaline 
 
 
Figure 7 Coronal view of the human 
brain. The blue arrows demonstrate 
the dopaminergic innervation that be-
gins in the substantia nigra and flows 
throughout the basal ganglia and 
eventually into the cortex.  PD degen-
eration occurs in the substantia nigra 
(SN) (containing the substantia pars 
compacts and the substantia nigra 
reticulate), which, along with the stria-
tum (the caudate and putamen nuclei), 
Globus pallidus, and the subthalamic 
nucleus make up the basal ganglia- 
the region of the brain associated with 
voluntary motor control. 
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Molecular insights  
The discovery of monogenic forms of PD heralded in a new age of PD research: 
one of mechanisms. Once the genetic players are identified, and proteins are 
consequently implicated, researchers can explore these molecules and what 
pathways they take part in.  
Several genetic loci have been identified in the recent years to be causal to PD, 
and their study gave us insights into mechanisms. It was shown that PINK-1 and 
Parkin a) interact with each other, b) are in the same pathway with Parkin as the 
downstream player, and c) are both involved in mitochondrial health in muscle 
and dopaminergic cells (Yang et al., 2006, Park et al., 2006, Clark et al., 2006). 
Another recent study proved the suspected mechanistic link between Gluco-
cerebrosidase (GBA) and α-synuclein. The group determined that this interac-
tion created a destructive feedback loop that resulted in increased aggregations 
of α-synuclein in the lysosome and eventually neurodegeneration (Mazzulli et al., 
2011).  
The lysosome in particular has been getting much attention in PD research. It is 
the site of all degradation in the cell and along with such mechanisms as chaper-
one-mediated autophagy (CMA) can specifically target harmful structures to the 
cell. α-synuclein is normally degraded in the lysosome. However, when α-
synuclein begins to aggregate, it becomes insoluble in this environment. Macro-
autophagy can to some extent deal with these large oligomers, but not beyond 
the point where the aggregates become toxic. The oligomers will eventually inter-
fere with lysosomal membrane integrity. The A53T mutation in α-synuclein exac-
erbates matters by interfering with CMA. Additionally, the PD mutation in LRRK2 
has been associated with impaired autophagy; as have mutations in PINK1 and 
Parkin in the mitochondria, leading to impaired mitophagy (autophagy of mito-
chondria) (Dehay et al., 2013).    
Despite the identified genetic causes of PD and the numerous mechanistic in-
sights their study provided, the precise molecular mechanisms that lead to do-
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paminergic degeneration in the SN are not yet fully understood, which is reflected 
in the lack of successful therapeutic interventions for PD. 
Cell death  
In seeking to further understand neurodegenerative diseases like Parkinson’s, it 
is imperative to develop knowledge in the area of cell death mechanisms. Cell 
death occurs both naturally, for example in digitation of fingers and human brain 
development or pathologically, like in the case neurodegenerative diseases. Var-
ious cell death pathways are outlined in Figure 8. 
General Overview 
There are three classical archetypes of cell death: apoptosis, autophagy, and ne-
crosis. They have all been described in literature and are respectively known as 
types I, II, and III12 (Kerr et al., 1972). However, many researchers dichotomize 
cell death into apoptosis or necrosis. In this approach, apoptosis involves caspa-
ses, and is non-immunogenic and programmed versus necrosis which does 
not involve caspases and is immunogenic and pathological (Galluzzi et al., 2012).  
Caspases are proteases that activate the apoptotic execution pathway (Black et 
al., 1988). The resulting cell death generally does not activate an external im-
mune response -in contrast with necrosis. During necrosis, cells swell in size 
along with their organelles and eventually the plasma membrane will burst. Intra-
cellular contents will be exposed to the extracellular environment, ultimately trig-
gering an inflammatory response and exposing the neighboring cells to stress  
12 The use of these labels (Type I etc.) has been discouraged by the NCCD in light of growing 
evidence that cell death molecules are active in more than one pathway and can be repurposed- 
making the lines between the mechanisms less distinct. 
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 and toxicity (Raff, 1992) (Kerr et al., 1972).  
 
Figure 8 Morphological contrast of apoptosis and necrosis from (Fink and Cookson, 2005). 
Oncosis refers to a gain in cell volume- in this image it is depicted as a form of necrosis. Pyropto-
sis is a caspase-dependent cell death pathway-however is also proinflammatory, thus putting it 
on the side of necrosis. This figure demonstrates the level of flexibility necessary in considering 
the various cell death modalities. 
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Yet, the clear contrast of apoptosis versus necrosis is not without its caveats. 
Caspase-independent forms of apoptosis have been described. Apoptosis can 
occur via three different pathways: extrinsic (death receptor based), intrinsic (mi-
tochondria based)13, and granzyme induced (Elmore, 2007). Although apoptosis 
was first described by Kerr as ‘’shrinking necrosis,’’ now that it has been molecu-
larly characterized the tables have turned and necrosis is defined in the negative: 
as not involving apoptotic or autophagic markers (Kroemer et al., 2009). Apopto-
sis can be controlled and prevented, and is a form of Programmed Cell Death 
(PCD) (Lockshin and Williams, 1965). It is often contrasted with necrosis in its 
utilization of built-in cell machinery. The characterization of necrosis as ‘’acci-
dental’’ or unprogrammed has been falling out of favor. In fact, it has been sug-
gested that various necrotic hallmarks have been evolutionarily conserved and 
are thus part of the essential cell machinery. In their review of molecular necrosis, 
Golstein and Kroemer compared necrotic cell death in six model systems14 and 
compiled a list of common features in the necrotic death program:  
• Mitochondrial dysfunction and swelling 
• Reactive oxygen species (ROS) production 
• ATP depletion15 
• Ca++ dyshomeostasis 
• Perinuclear clustering of organelles 
• Activation of proteases (calpains and cathepsins) 
• Lysosomal rupture 
• Plasma membrane rupture 
It should be stated that not one model organism or system showed evidence of 
all of these features. The exact events of the necrotic death pathway seem to be 
13 The distinction between extrinsic and intrinsic is not rigid, and molecules from either pathway 
can influence each other (Igney and Krammer 2002). 
14 The systems and their inducers (in parentheses): L929 (Tumour Necrosis Factor), primate neu-
ronal cells (ischemia), rabbit kidney cells (antimycinA), human T cell lines (Anti-Fas and others), 
C. elegans neuronal cells (mec-4(d) and others), and D. discoideum (dev. signals in atg- mutants).  
15 A crucial distinction between apoptosis and necrosis is ATP utilization. In necrosis, ATP is 
characteristically reduced and in apoptosis, it is increased in order to carry out the classical 
mechanism. 
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dependent on mode of activation (Golstein and Kroemer, 2007) or require a more 
stringent and biochemical characterization of the necrotic event, per the updated 
NCCD guidelines (Galluzzi et al., 2012). The attempt to unify the observed ne-
crotic events into a single cohesive pathway has not reached a point where it is 
consistently reproducible or conserved. Its failure exposes the need for increased 
study of cell death and possibly an acceptance that the cell death pathways are 
homeostatically complex. There is a mix of pro-death and pro-survival pathways 
in the cell and levels of stress will influence the crosstalk between them (Raff, 
1992). Additionally, it has been seen that in some cases if one pathway is inhibit-
ed, the cell can switch to one of the other pathways (Nicotera and Melino, 2004).  
Autophagy involves the formation of autophagosomes that fuse with lysosomes 
and initiate degradation of intracellular material. There are three types of autoph-
agy and they are characterized by the method of content delivery: macroautoph-
agy, microautophagy, and chaperone-mediated autophagy (CMA). Though the 
specificity of autophagy is in question, recent studies have shown that the au-
tophagosome does distinguish amongst healthy and dysfunctional components in 
the cell, and can contribute to pro-survival mechanisms. However, too much acti-
vation of the macroautophagy machinery can either trigger apoptotic mecha-
nisms or engage in excessive and terminal autophagy (Klionsky, 2007).  Levine 
and Kroemer propose that with the current evidence available it is impossible to 
call autophagy a ‘’bona fide killing event.’’ Rather, they suggest that autophagy is 
merely involved in the upstream events of both apoptosis and necrosis. Thus, the 
dichotomization of cell death into apoptosis or necrosis is an appropriate move 
(Kroemer and Levine, 2008). Importantly, if autophagy machinery is interfered 
with, cell death events increase.  
The study of cell death has gone through many paradigm shifts and as such has 
accumulated terminology (Kroemer and Levine, 2008). Yet, it is no mystery why 
this problem exists. As the cell death pathways are only partially defined (except-
ing apoptosis), scientists observe death events that embody characteristics of 
many pathways and give them distinct names, although these pathways might 
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not reflect standalone cell death mechanisms. Some examples of these are: mi-
totic catastrophe, anoikis, excitotoxicity, Wallerian degeneration 16, paraptosis, 
pyroptosis, pyronecrosis, and entosis. To address these concerns, the Nomen-
clature Committee on Cell Death (NCCD) was formed17. It strives to establish 
‘’non rigid and yet uniform’’ guidelines in the description and characterization of 
cell death to move cell death research forward from a morphological basis to a 
biochemical one (Galluzzi et al., 2012, Kroemer et al., 2009).  
Neuronal death 
Neurons are no strangers to cell death. In fact, apoptosis is a necessary step in 
brain development. By birth, only 10% of neurons remain in the brain because 
during brain development many more neurons are differentiated than required. 
From this pool of neurons, only the ones that can form strong synapses and 
properly follow neurotrophic and semaphore signals are “deemed worthy”- the 
others ‘’commit suicide’’ by undergoing apoptosis.  
Besides developmental cell death, neurons are also prone to pathological cell 
death, commonly via neurodegenerative disorders. As excitable cells, neurons 
are prone to aberrant excitation. Imbalances in intracellular homeostatic path-
ways, like oxidative stress, mitochondrial dysfunction and calcium overload the 
cell and can mobilize apoptotic and necrotic cell death mechanisms that result in 
neurodegeneration (Mehta et al., 2013). Further, there is another mechanism of 
death peculiar to neurons. This mechanism, Wallerian degeneration, involves the 
death of axons, but not of the cell body. In studies of the WldS protein, which is 
responsible for carrying out the axonal degeneration, knockout results in axonal 
protection, but not soma protection (Conforti et al., 2007). In some neurodegen-
erative disorders like Parkinson’s disease, there is a theme of how neurons die: 
axons first then cell bodies (Chu et al., 2012).  
16 Wallerian degeneration, or the death of axons, is indeed a distinct event- however- it is not a 
cell death mechanism, as the death of an axon is not preclusive to the death of the soma. 
17 The NCCD was formed from Nature Publishing Group’s journal Cell Death and Differentiation 
and published recommendations in 2005, 2009, and most recently in 2012. 
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C. elegans as a model to study DA degeneration 
It was in C. elegans that apoptosis was worked out by Sulston and Horvitz. By 
laboriously documenting the lineage of all the organism’s cells, they were able to 
show that approximately 13% of somatic cells in the embryo die predictably. With 
this, they opened the door to a genetic basis of cell death and consequently to its 
mechanistic study and understanding (Lockshin and Zakeri, 2001). The impact of 
work done in C. elegans research cannot be overstated and it has been a crucial 
player in scientific discovery. Sydney Brenner, the founder of the field, jokingly 
said in his 2002 Nobel lecture that, ‘’without doubt the fourth winner of the Nobel 
prize this year is Caenohabditis elegans it deserves all of the honour but, of 
course, it will not be able to share the monetary award.’’ Five C. elegans scien-
tists have received three Nobel prizes since the beginning of this century18.  
 C. elegans was the first organism for which there was a completed ‘’connecto-
me,’’ the entire nervous system wiring map. While it does not have a brain, the 
worm does have a nerve ring and exactly 302 neurons in the hermaphrodite’s 
nervous system. Among its 302 neurons, there are eight dopaminergic (DA) neu-
rons, illustrated in Figure 9A, that exist in four pairs; two each of: ventral cephalic 
(CEPVs), dorsal cephalic (CEPDs), anterior deirid (ADEs), and posterior deirid 
(PDEs) (Sulston and Horvitz, 1977). Current estimates of human DA neurons are 
in the ballpark of 500,000 (Bjorklund and Dunnett, 2007). Though there is a large 
quantitative gap between eight and 500,000, functionally speaking, dopaminergic 
neurons in C. elegans and humans are comparable. Figure 9B shows the syn-
thesis pathway of DA in a generic neuron and synapse, and demonstrates the 
strong conservation of this basic pathway between C. elegans and humans. 
18 2002: Brenner, Horvitz, and Sulston for the genetics of organogenesis and programmed cell 
death; 2006: Fire and Mello for work on RNA interference (RNAi); and 2008: Chalfie for green 
fluorescent protein (GFP).  
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  Another strong point of conservation between humans and C. elegans is within 
PD genetics. Orthologs of human PARK genes are found in the C. elegans ge-
nome C. elegans (Dexter et al., 2012). One important gene in neurodegenerative 
disease not conserved in humans and nematodes is α-synuclein. However, using 
microinjection or bombardment, transgenic lines may be easily generated in C. 
elegans (Tucci et al., 2011). Thus, human α-synuclein was introduced into C. el-
egans. Remarkably, the overexpression of wild type or mutant α-synuclein re-
sulted in neuronal degeneration. This result elucidated some mechanisms of α-
synuclein toxicity (Lakso et al., 2003).  On one hand, this is not a directly appli-
cable result in humans. The α-synuclein protein in this case is foreign. On the 
other, one can observe the exact actions of the protein, mutant and wildtype, 
without interference from the endogenous copy (Dexter et al., 2012).  
C. elegans is an ideal model organism for basic research within neuroscience. As 
Brenner said, ‘’So genocentric has modern biology become that we have forgot-
ten that the real units of function and structure in an organism are cells and not 
A 
 
B 
 
Figure 9 Dopaminergic (DA) neurons in C. elegans exist in 4 symmetrical pairs, seen in A: 
CEPVs (purple), CEPDs (blue), ADEs (yellow), and PDEs (green). The nerve ring is also shown 
in green. The ADEs, PDEs, and CEPDs are part of the nerve ring’s innervation. B shows the do-
pamine pathway genes and conserved orthologs in C. elegans (gene on top and bolded) 
(Doitsidou et al., 2013). 
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genes’’ (Brenner, 2003). Because of its transparency, expression of GFP-tagged 
proteins can be observed in vivo. Gene knockdown is made simple with RNAi 
and knockouts are available almost genome wide in C. elegans. Nature can be 
manipulated and observed in this organism. Moreover, though simple, its cellular 
machinery is comparable to that of humans. Its simplicity is indeed an advantage 
in the case of the nervous system. Establishing basic mechanisms in C. elegans’ 
dopaminergic neurons will lead to building the foundation for understanding 
equivalent mechanisms in humans.  
Basic C. elegans biology 
C. elegans has a predictable and short lifecycle, producing progeny within ap-
proximately three days at 25º, four days at 20º, and three days at 15º (Figure 10 
for the standard 25º lifecycle).   
C. elegans is a dioecious species: consisting of a hermaphrodite, five autosomes 
and two sex chromosomes (XX), and a male, five autosomes and one sex 
chromosome (XO) (Herman, 2005) (Pictured in Figure 10B). Hermaphrodites 
can be singled to plates and will self-fertilize. Genetic crosses in C. elegans 
depend on the preferential use of the male sperm to the hermaphrodite’s own 
sperm. Male sperm is larger and can crawl faster (Singson et al., 1999).  
However, males occur one out of every five hundred animals in WT population. 
Males are the result of an X chromosome non-disjunction event during meiosis. A 
male, if crossed with a hermaphrodite, will result in a population with 50% 
occurance of the event, a 50/50 male/hermaphrodite population; if one 
spontaneous male is found it can be mated with a hermaphrodite to produce a 
male-enriched population. Alternatively, a high incidence of male (him) strain can 
be used, Finally, the event can be induced with heat shock (Hodgkin et al., 
1979).  
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Figure 10 A model genetic organism. A shows the C. elegans lifecycle at 25º. Figure from (Jorgensen 
and Mango, 2002).  B and C refer to Crossing C. elegans. In A the L4 life stage is shown, characterized by 
the half-moon shape in the middle of the worm. For mating, a worm slightly older should be selected, as 
seen in B. The male is superiorly located in relation to the hermaphrodite. Images were taken by the au-
thor with an iPhone 5 camera and on a dissecting scope. 
A B 
C 
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Experimental Methods 
C. elegans  
Standard C. elegans care and maintenance was followed for this thesis as previ-
ously described (Brenner, 1974). N2 was the wild type (WT) strain. C. elegans 
strains were obtained from the CGC19 unless otherwise noted.  
Strains are kept on nematode growth medium (NGM) seeded with the OP50 
strain of E. coli in circular petri dishes (Stiernagle, 2006). Organisms destined for 
screening or whole genome sequencing (WGS) were propagated on larger di-
ameter plates coated with HB101 E. coli to facilitate larger populations.  
Working strains used for this thesis were kept at 20ºC unless otherwise noted. 
Before using a strain for experimentation, it was maintained in a well-fed and 
‘clean’ state for at least two generations. Cleaning from contamination was ac-
complished through picking worms to new plates or when needed ‘’bleaching’’ 
with a fresh solution of standard bleach:1 M NaOH (1:1).  
Genetic Crosses and Strains 
Heat shock (HS), 45 minutes to one hour at 37º, was used perferentially in this 
thesis to produce males. Detailed crossing plans for special cases 20 can be 
found in the Crossing Schemes section of the Appendix. Crosses were con-
ducted at 20º. A generalized srossing scheme is depicted in Figure 11. A feature 
of trp-4(d) mutants is the inability of males to produce progeny; the cause for this 
has not been determined so it cannot be said whether males are infertile or are 
19 funded by NIH Office of Research Infrastructure Programs (P40 OD010440) 
20 Three crossing plans: general, involving the X chromosome, and crossing on the same chro-
mosome are diagramed.  
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incapable of mating. In any case, the result of this is that males must be made 
from  
 
the animals mutated for the Gene of Interest (GoI) that is intended to be crossed 
to trp-4(d). Strains built for this thesis are listed in Table 1. Strains were frozen 
with 15% glycerol solution (Stiernagle, 2006). 
 
  
 
For this schematic, we as-
sume that the Gene of Interest 
(GoI) is on a different chromo-
some than trp-4.. 
 
GoI strain males are produced 
through HS to yield homozy-
gous GoI(*/*) 
 
Seven hermaphrodites and 
fifteen males (or a similar ra-
tio, always favoring males) are 
placed onto empty plates and 
given food. P0 generation. 
 
Hermaphrodites are singled 
from the first filial generation 
(F1).  
 
The success of the cross can 
be determined by observing 
the F1 generation. If there is 
an abundance of males then 
the cross worked. 
 
In the F2 generation thirty hermaphrodites are singled from a cross-progeny plate. The singled 
F2s are selected for degeneration, fluorescence, and for GoI phenotype (if any). 
 
In F3 generation, the picked strains are confirmed with genotyping. Once the target strain is 
achieved, the experimenter will score the severity of degeneration. 
 
Figure 11 Generalized Crossing Scheme for trp-4 (ot337) and an arbitrary gene of interest. 
In this scheme, a trp-4(ot337) is the hermaphrodite used in the parental cross. For chromosomes: 
purple indicates LG1, blue indicates LG[random], straight lines from the hermaphrodite, and 
dashed from the male. A circled X means self-cross. This generalized scheme is a guideline, and 
neglects much of genetics, including recombination. Fluorescent marker is shown with green. The 
target strain is outlined in the third filial generation by a green circle. 
P0 
F1 
F2 
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Genotyping 
To confirm the genotypes of the generated strains, PCR and gel electrophoresis 
were used for deletion mutants, PCR and DCAPs digestion or PCR and sanger 
sequencing were used for point mutations, and assessment of obvious pheno-
types were used in all cases to determine correct strains.   
Primer Development 
There were two three different kinds of primers used in this thesis: standard, 
nested, and DCAPS; the latter two were usually combined. Standard primers 
were developed in one of two ways. Primers could be developed using the Pri-
Table 1 Strains built for the thesis are listed in this table. Alleles are in parenthesis and LGs are bolded. vtIs1 
is routinely used in this lab and its genotype (DAT-1::GFP) is often not mentioned. According to convention, 
genes on the same chromosome are separated by commas and genes on different chromosome are separated 
by semi-colons. Under the heading project, the purpose of the strain is indicated. 
Strain Genotype Description  Experiment 
MDH171 norSci1_[dat1::Trp-4(d)_unc-
119]II;unc-119(ed3)III;vtIs1V 
This is the screening strain with 
the ‘’endogenous’’ copy of trp-4 
crossed out.  
Forward genetic screen 
MDH202 trp4(ot337)I;vtIs1V;Glo-1(zu391)X For scoring neurodegeneration Lysosomal biogenesis 
MDH203 trp-4(ot337)I;vtIs1V; vha-3(ok1501)IV For scoring neurodegeneration Involvement of V-
ATPase 
MDH240 trp4(ot337)I;vtIs1V;Vha-12(n2915sd)X For scoring neurodegeneration Involvement of V-
ATPase 
MDH241 zdIs5(mec-4::GFP)I;mec-4 (u231)X Developed as control for sup-
pression experiments 
Control 
MDH249 trp4(ot337)I;vtIs1V;Unc-32 (e189)III For scoring neurodegeneration Involvement of V-
ATPase 
MDH250 Unc-32(e189)III;vtIs1V; him-
8(e1429)IV 
Obtained from cross of MDH285 Involvement of V-
ATPase 
MDH251 Unc-32 (e189)III;vtIs1V Control for scoring strain 
MDH285 
Involvement of V-
ATPase 
MDH285 apb-3(ok429)I,trp4(ot337)I;vtIs1V For scoring neurodegeneration Lysosomal biogenesis 
MDH286 apb-3 (ok429)I; vtIs1V Control for scoring strain 
MDH285 
Lysosomal biogenesis 
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mer BLAST tool on the NCBI database or by-eye. Generally, primers developed 
with Primer3 software yielded more consistent results. NCBI uses the Primer3 
development algorithm to find the best primers. This has many advantages, in-
cluding reporting of failed primers and thus constantly updating algorithm. It also 
gives the molecular analysis of the primer. It incorporates its own BLAST tech-
nology, automatically analyzing the specificity of the primer (Ye et al., 2012).  
All primers were analyzed by the IDT technologies OligoAnalyzer 3.1 DNA calcu-
lator. Furthermore, if primers were not analyzed for sequence homology in the 
NCBI BLAST algorithm, the BLAT algorithm on WormBase was utilized, written 
by Jim Kent21. This can be found on the WormBase website. It works by compil-
ing the genome based on non-overlapping 11 bp fragments. Either BLAST or 
BLAT must be used to ensure primer specificity- especially when the primers are 
designed by eye.  
DCAPs are a kind of primer that makes detection of single nucleotide polymor-
phisms (SNPs) possible with standard electrophoresis. The program works by 
comparing the sequence with the SNP and without. It then find a specific re-
striction site including the SNP which will allow one to differentiate the two se-
quences (Neff et al., 2002). A high % agarose matrix must be used (3.3-3.5%) in 
order to detect the shift. This method has become irreplaceable in this lab, as the 
trp-4(ot337) mutation is detectable with DCAPs primers and does not have to be 
sent for sequencing every time a strain is being built. Briefly: a normal PCR is run 
with one of the primers developed by the DCAPs program and another devel-
oped by the experimenter, the sample is digested with the specific enzyme indi-
cated by the program, and the sample is run on a high% agarose matrix and 
compared relative to the controls.  
All of the primers used in this thesis can be found in the Primers section of the 
Appendix. They are given the generic chronological formula of: [author’s ini-
tials][the next number on the list][directionality 3’->5’], ie TP1F. 
21 http://www.kentinformatics.com/  
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PCR 
PCR was conducted as standard, following the pipetting scheme and PCR pro-
gram in Figure 12. The pipetting scheme in A is adapted from the recommended 
PCR mix in the TAQ polymerase information packet. The general program in B is 
adjusted as needed: The TA is typically set at 2º less than the primer Tm. The 
elongation time is adjusted to the 1min per 1kb formula set forth in the Thermo 
Scientific TAQ polymerase information packet. Heterozygous PCR controls were 
acquired by mixing half WT and half mutant controls.  
Sequence Analysis 
Sanger sequencing was performed by Macrogen. The samples sent were 
cleaned according to the protocol provided in (Werle et al., 1994). Sequences 
were aligned by DNAsequencer software and homozygosity was determined.  
RNAi 
RNAi, or RNA interference, is a knockdown method useful in C. elegans. Either 
by injection, soaking, or feeing, a double stranded (ds) nucleotide sequence is 
introduced to the worm. Upon recognition of dsRNA, the cell is cued to degrade 
all matching sequences, effectively knocking down the gene of interest (Ahringer, 
2006). Unfortunately, this take-up is not efficient in the nervous system. 
(Timmons et al., 2001). In order to carry out knockdown system-wide, including 
A B 
General Pipetting Scheme for PCR Reactions 
Reagent Amount (µL) x1 RXN 
10x DreamTaq Buffer 2.5 
10 mM dNTPs 0.5 
Forward Primer 0.5 
Reverse Primer 0.5 
Template 4.0 
TAQ 0.4 
H2O 16.6 
Total Volume 25.0 
 
General Program for PCR Reactions 
Step T (Cº) Time 
Initial Denaturing 95 3’ 
Denaturing 95 20’’ 
Annealing 57 30’’ 
Elongation 72 1’ 
Final Elongation 72 5’ 
 
 
Figure 12 PCR protocols A shows 
the pippetting scheme for a master 
mix. B shows the general temperature 
program for the reactions.  
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the nervous system, a strain sensitized to RNAi is utilized (Sieburth et al., 2005). 
Effectiveness of RNAi was determined dually. First, the known phenotypes of the 
mutations were considered, in this case: developmental and embryogenesis de-
fects were observed. Note the gonads of A and B in Figure 13. There are clear 
embryogenesis defects in the VHA-11 RNAi organism (A) compared with the or-
ganized and compact development seen in B. Secondly, an RNAi clone of known 
effect was used as a positive control indicative of the success of general RNAi 
experimental conditions (Nagarajan et al., 2014). Though this could not justify 
any positive or negative results, it could shed doubt on the scoring if the known 
results were not replicated. In this thesis, trp-4(d)(ot337);eri-1;lin-15b;vtIs1I, was 
used for RNAi experiments. Clones were grown with the standard HT115 strain 
of bacteria.  
 
All possible vha (controlling the V-ATPase pump) genes were considered. Most 
of the genes are embryonic lethal- making experimentation at the L4 stage diffi-
cult indeed. To overcome this, the progeny of RNAi-fed L4 animals were scored. 
This was done so that some of the maternal development programs could be 
properly initiated. Survival rates were very low in all cases, and in the case of 
VHA-4, nothing could be done to alleviate the effects of its absence.  
 
 
 
 
 
Figure 13 Effectiveness of RNAi. A and B both show adult animals. A was fed on VHA-11 RNAi 
B is a WT worm fed on OP50. 
B A 
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Pharmacological inhibition of V-ATPase pump 
Bafolimycin A (50μM, Sigma) was injected into the body cavity of the worm as 
previously described, (Syntichaki et al., 2005), to inhibit the V-ATPase pump 
pharmacologically. The chemical was injected into the body cavity. The chemical 
was dissolved in DMSO (Sigma) and the mix was brought to concentration with 
nuclease free water. DMSO and nuclease free water served as the experimental 
control.  
Microscopy 
To select worms with fluorescent markers during crosses, the Zeiss Discov-
ery.V12 stereoscope was used. Scoring dopaminergic head neurons was com-
pleted with the Zeiss imager M.2 microscope. Differential interference contrast 
(DIC) was integrated into this microscope and was used for scoring and visualiz-
ing morphology. Images were taken and created by the Zeiss software.  
Scoring 
For dopaminergic and mechanosensory degeneration: In the scoring book, cells 
were counted as: 1 (healthy soma and healthy dendrite), ł (soma but no dendrite), 
and 0 (neither a healthy soma nor dendrite). Swollen, shrunken, and rounded 
cells were not considered healthy. Neurons with faded nuclei were not consid-
ered healthy. Dotted or interrupted projections were not considered healthy. Ab-
sence of either was scored as 0. Worms were immobilized with 50μM sodium az-
ide. 
Development of transgenic line 
To visualize the lysosomes during trp-4(ot337)-induced cell death, the (Lyso-
some associated membrane protein) LMP-1 lysosomal marker (Kostich et al., 
2000) was cloned under a DAT-1 promoter (Figure 14), and microinjected into 
the trp-4(ot337) strain. 
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Cloning 
LMP-1::GFP was amplified from strain unc-119(ed3);pwIs50. pwIs50 [lmp-1::GFP 
+ Cbr-unc-119(+)]22 (Treusch et al., 2004). Primers TP64F and TP65R23 were 
used to amplify the LMP-1::GFP fusion from this strain (Figure 14A); their se-
quences can be found in the Crossing Schemes section of the Appendix. The 
high fidelity Phusion enzyme (Thermo Scientific) as the resulting fragment is 
quite large at 1803 bp. The band was excised and gel purified according to the 
Quiagen Gel Extraction Kit protocol. The PCR product and vector were cut with 
Thermo Scientific enzymes KpnI and EcoRI in a double digest. In the vector, the 
enzymes cut out GFP (Figure 14B). Ligation and transformation were performed 
as standard; DH5α was used as competent bacteria for transformation. Colonies 
grew in both V+H2O and V+I plates, with more on the later. Colonies were sub-
jected to a colony PCR (Figure 14C). The colonies with V+H2O did not show any 
band, meaning the vector did not take up insert. Three colonies V+I showed a 
positive PCR result. Two of these were chosen for a culture PCR, along with one 
of the V+H2O colonies. Curiously, all three colonies showed positive for LMP-
1::GFP, indicating that the V+H2O sample was contaminated at some point 
(Figure 14D). the colonies were sequenced with three different primers anneal-
ing to the pDAT-1 sequence, outside GFP, and within GFP. LMP-1::GFP was 
successfully cloned into the pPD95.75 plasmid (Figure 14E)  (AddGene) with 
DAT-1 promoter (Figure 14F). There was an alternative strategy involving clon-
ing LMP-1 in between dat-1 and GFP in the pPd95.75 vector. However, no colo-
nies grew.  
 
 
 
 
22 Ordered from CGC. 
23 Note that TP65R will not anneal in a WT worm, as it anneals to the COOH terminus of GFP.  
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A 
B 
 
E 
 
   
 
C 
 
D 
 
Figure 14 Cloning of LMP-1::GFP 
into pPD95.75 under pDAT-1.  A 
shows the product of the Phusion 
PCR: Ladder, LMP-1::GFP strain 
(M), WT strain, and HET. B shows 
the digested M, uncut M, dig WT, 
uncut WT, dig vector, and uncut vec-
tor. Both inserts and the vector were 
cut with EcoRI and KpnI in Cfr91 
buffer. C Shows the colony PCR. 
The first two lanes on the top row 
are Vector +H2O. The last two lanes 
on the bottom row are mutant lysate 
PCR product and pDat vector. The 
other lanes are Vector+Insert colo-
nies. D shows the culture PCR E 
The pPD95.75 vector with pDAT-1 
before digestion F The pPD95.75 
vector + LMP-1::GFP insert (Yel-
low+green is the insert). GeneRuler 
DNA Mix Ladder is featured in all gel 
images. Plasmid schematic generat-
ed by the ApE software- 
F 
 
 
 
 
  
pPD95_75
4875 bp
UNC-54 3UTR 1557..2255
GFP_with_gaps 522..1391
Artificial intron 450..491
dat-1promoter 19..418
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Microinjection  
To realize the cloned plasmid in vivo, it must be introduced into the genome of C. 
elegans. The injected plasmids were introduced extrachromosomally. The tech-
nique of microinjection utilized is thoroughly described in the C. elegans Mi-
croinjection Protocol written by Catarina Silva of Northwestern University. The 
microinjection mix was made with the newly obtained plasmid24 from the LMP-
1::GFP cloning and selected coinjection markers (roller for easy picking and PBS 
for weight) with a total ideal mass of 150ng (Table 2). A dark trp-4(ot337) strain 
was used for injection, as the transgene had a GFP in it. Young adults were used 
for injection. The animals were picked to an empty plate and left to roam for an 
hour. This mildly starves the worm, but it also allows the animal to defecate 
which makes visualization of the gonad easier. The animals were picked to a de-
hydrated 2% agarose pad into a drop of injection oil. After injection, the worm 
was gently moved to a fresh plate full of food and rehydrated with 9 μL of M9 
buffer. A Leica inverted DIC microscope with a movable stage was used to view 
the worms during injection. An Eppendorf FemtoJet express was used as the in-
jection device. Pre-made injection needles were purchased from Eppendorf.  
Preconditioning 
The HS preconditioning experiment was performed as previously described 
(Kourtis et al., 2012). Breifly: adult animals, zdIs5;mec-4(u231) and trp-
4(ot337);vtIs1, were bleached and the eggs centrifuged and washed with M9 
buffer. Eggs were suspended in M9 and subjected to a water bath treatment, one 
24 Quiagen DNA purification kit was used for plasmid purification. 
Table 2 Extrachromosomal lines generated during the thesis are listed in this table. trp-4(ot337), notably 
without any reporter, was used as the starting strain for the injection.  
Strain Genotype Description  
MDH242 norEx86[Pdat-1::lmp-1::gfp;rol-6];trp-4(ot337) Lmp-1 injected at 10 ng/ul, 40 ng/ul 
rol-6, and 80 ng/ul PBS into strain trp-
4(ot337). 
MDH296 norEx86[Pdat-1::lmp-1::gfp;rol-6] generated by crossing out trp-4(ot337) 
from strain 
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group of each genotype at 20ºC and one at 34ºC, for twenty-five minutes. All four 
groups were transferred to agar plates with NGM (Kourtis et al., 2012). In devia-
tion from the protocol: after bleaching and washing, eggs were kept nutating at 
RT for four to five hours. This step was altered to ensure that embryos would 
have a gentle environment to hatch after the stressful heat shock treatment. 
Forward genetic Screen 
The forward genetic screen was conducted in accordance with the protocol de-
scribed in (Doitsidou et al., 2008) (Figure 15A). EMS was used as the mutagen. 
The COPAS BioSort worm sorter was used to automatically screen mutants. 
Three rounds of screening were completed by the author (Table 3). Confirmed 
mutants can be found in the Results and Discussion section.  
 
The screening strain was norSci1_ [dat1::Trp-4(d) _ unc-119] II; unc-119(ed3)III; 
trp-4(ot337)I;vtIs1. This strain has two copies of the mutated channel: one on 
chromosome I (endogenous) and one on chromosome II (Mosci inserted). Addi-
tionally, another strain was created in which the endogenous copy was absent. 
Thus, there were three relevant combinations: the original strain with one copy of 
the mutated channel on chromosome I, a strain with a copy of the mutated chan 
nel on chromosome II, and a strain with two copies of the mutated channel- one 
each on chromosome I and II. The three are compared for levels of degeneration 
in Figure 16. It seems, as previously suspected by Nagarajan et al, that degen 
eration is dependent on dosage of the mutated trp-4(d) gene.  
Table 3 Screening Rounds Screening strain ‘530’ is norSci1_ [dat1::Trp-4(d) _ unc-119] II; unc-119(ed3)III; 
trp-4(ot337)I;vtIs1 
Screen round Strain Mutagenesis date #P0s mutagenized #F1 plated #F2s screened 
NorMut1 530 05.08.2013 2650 2750 ~1000 
NorMut2 530 15.08.2013 11910 45000 50400 
NorMut3 530 16.09.2013 6267 54900 
eggs 
TBD 
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  Suppressor selection was automated by selecting for the highest levels of GFP 
(Figure 15B). Isolated candidate suppressor mutants were confirmed for their 
partial or full suppression of degeneration. Suspected partial mutants were con-
firmed by scoring against trp-4(ot337);vtIs1. This strain was chosen over the 
screening strain because it had more head neurons than either of the other two 
strains. Thus, if a strain was found to be significantly better than it, it could be 
considered a true suppressor. Suspected full suppressors were confirmed to be 
intergenic by crossing to a wild type strain (otIs356[rab-3::NLS::tagRFP]V;him-
8(e1489)IV). The F1 generation was observed for degeneration. If it was ob 
served, the mutant was a recessive full suppressor and if none was observed, 
ten to twenty individuals were singled. If their progeny did not exhibit degenera-
tion, the mutation was deemed intragenic, if it did, it was declared a dominant 
suppressor. 
A 
 
B 
 
 
 
Figure 15 The Unbiased Approach. A is a schematic developed by (Doitsidou et al., 2008) and 
shows the process of automated forward genetic screening. B shows that a strain with two copies 
of trp-4(ot337) was mutagenized with EMS. The ideal output of the screen would be a worm with 
increased expression of GFP, meaning increased number of dopaminergic neurons. 
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WGS sequencing was provided by 
BGI Tech Solutions (Hong Kong). The 
genomic samples sent were cleaned 
according to the protocol provided with 
the DNeasy Blood and Tissue kit. 
Samples were left to rest in the elution 
buffer >24 hours after precipitation be-
cause they did not dissolve following 
the standard protocol and time.  
Statistics  
Normalcy of the population was de-
termined by plotting the values for av-
erage head neurons per worm of a 
population of trp-4(ot337) group of animals on a frequency histogram, Figure 17. 
The distribution is close to Gaussian, and thus parametric testing is appropriate. 
Additionally, the D’Agostino & Pearson omnibus normality test found the popula-
tion to be consistent with Gaussian assumptions in the Prism6 (GraphPad) soft-
ware.  
After scoring, values for degeneration were entered into Excel 2010 (Microsoft). 
‘1’ was entered if the soma and dendrite were present and ‘0’ if either was miss-
ing. After all values were entered, each dopaminergic class was individually 
summed and divided by the number of individuals scored. Individual values 
ranged between 45 and 55, though the ideal value was 50. The standard error of 
the means (SEM) was calculated within Excel by dividing the standard deviation 
of the values by the square root of individuals scored. Statistical analysis was 
continued in a separate software. 
 
 
 
Figure 16 Comparison of strains with trp-
4(d). ‘’Mosci’’ refers to the copy of trp-4(d ) that 
was inserted using the Mosci method. 
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  All statistics and graphs were generated by 
the Prism6 software (GraphPad). For calcula-
tions of separate dopaminergic classes, two-
way ANOVA was performed. For comparisons 
of total head neurons, one-way ANOVA statis-
tical regression was performed and the un-
paired t-test with Welch’s correction (As the 
means had variance in the SD.). Multiple 
comparisons were achieved using Sidak’s 
post hoc analysis. Significance was attained 
when p<0.05. Significance assignments in 
Prism6 software: *=0.05, **=0.005, ***=0.0005, 
and ****=0.00005. 
Literature Search 
The starting place for the literature search was 
papers used during the experimental proce-
dures. Beyond the methods of these papers were introductions and discussions 
containing references of previous experimentation. These sources were read and 
also scoured for further sources relevant to the field. 
Google Scholar in particular was a useful search engine for this thesis. The 
search algorithm used also included the UiS proxy for access to publications. 
Thus, no searching for papers through the university systems was required. 
Many of the Google Scholar links used NCBI’s PubMed database. 
 
Figure 17 Distribution of trp-4(d) 
degeneration is shown here in a fre-
quency histogram. The histogram was 
created by Dr. John MacDonald of the 
University of Delaware. The graph 
shows the distribution of the total 
head neurons (min=0, max=6) for a 
population of trp-4(ot337) animals 
(n=82).  
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The UiS database was connected to remotely when not at a UiS computer with 
the Bibsys25 network, which connects all of the Norwegian libraries and their ac-
cess rights. UiS utilizes the Oria search system, provided by Bibsys. 
EndNoteX7 was used to compile the references. ReadCube was used to organ-
ize, read, and notate relevant PDF documents.  
  
25 Accessed remoted with the URL: http://www.uis.no.ezproxy.uis.no/ 
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Results & Discussion 
Candidate approach 
Effect of V-ATPase lysosomal acidification  
trp-4(d)26 mutants exhibit severe and progressive degeneration in their dopamin-
ergic neurons. In order to assess whether the function of V-ATPase (vacuolar H+ 
ATPase) pump is important for the dopaminergic cell death induced by trp-4(d), 
both genetic and pharmacological methods were employed. The V-ATPase 
pump has two sectors based on their location on the lysosomal membrane: the 
V0 sector of the pump is cytoplasmically located, while the V1 sector is mem-
brane-bound. Subunits from both sectors were tested by crosses and RNAi. Var-
ious V-ATPase subunits were prioritized for testing based on the following crite-
ria: 
• Reported expression in the nervous system 
• Previous implication in necrotic cell death in mechanosensory neurons 
(Syntichaki et al., 2005)  
• Availability of mutants/ RNAi clones 
 
A summary of the vha genes can be found in Table 4. 
Genetic Approach  
VHA-12 is responsible for encoding a major subunit of the V0 sector. It is required 
for embryogenesis as well as morphogenesis; vha-12 null mutations are lethal. In 
a screen for jerky locomotion, the Jorgensen lab isolated a viable semi-dominant 
allele in the vha-12 locus, n2915sd27. This allele is a substitution of a highly con-
served amino acid position, A385, that likely results in impaired ATP catalysis 
(Ernstrom et al., 2012). It was previously shown to suppress mec-4(d) degenera 
26 trp-4(ot337) is used interchangeably with trp-4(d). 
27 Kindly provided by the Jorgensen lab at the University of Utah. 
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 tion (Syntichaki et al., 2005). A double mutant of vha-12(n2915sd) and trp-
4(ot337), with vtIs1[dat-1::GFP] in the background, was created to see if the 
VHA-12 protein has an involvement in trp-4(d) induced degeneration. L4 animals 
of this strain were scored against trp-4(ot337);vtIs1 and vtIs1 itself (omitted from 
the graphs) (Figure 18). Figure 18A shows that significant differences were ob-
served between the strains when scoring individual classes of head neurons 
(CEPV, CEPD, and ADE), but no such difference when comparing the total head 
neuron counts. While the CEPs showed a small but significant protection from 
Table 4 V-ATPase pump genes and their expression patterns and mutant phenotypes. In 
column one, an asterisk indicates known neuronal expression. All genes tested in mec-4(d) gave 
suppression. This table is adapted from Table S1 in (Syntichaki et al., 2005) 
 
Gene Sector, Subunit Allele/RNAi Effect in mec-4(d)  Comments and Outcomes 
vha-1 V0, c-subunit RNAi n/a lethal 
vha-2* V0, c-subunit n/a yes RNAi sequence not correct  
vha-3 V0, c-subunit ok1501 n/a mild effect 
vha-4 V0, c’’-subunit RNAi n/a lethal 
vha-5 V0, a-subunit n/a n/a RNAi not available 
vha-6 V0, a-subunit RNAi n/a no effect 
vha-7 V0, a-subunit ok1952 n/a cross could not be completed 
vha-8 V1, E-subunit n/a n/a RNAi available, not completed 
vha-9 V1, F-subunit n/a n/a RNAi available, not completed 
vha-10* V1, G-subunit RNAi yes no effect 
vha-11 V1, C-subunit RNAi no inconclusive 
vha-12* V1, B-subunit n2915sd yes mild effect 
vha-13 V1, A-subunit n/a n/a RNAi sequence not correct 
vha-14 V1, D-subunit n/a n/a RNAi sequence not correct 
vha-15 V1, H-subunit n/a n/a RNAi available, not completed 
vha-16 V0, d-subunit n/a n/a RNAi not available 
vha-17 V0, e-subunit RNAi n/a inconclusive 
vha-18 V1, H-subunit n/a n/a RNAi available, not completed 
vha-19 V0, AC45-subunit n/a n/a RNAi available, not completed 
spe-5 V1, B-subunit hc93 yes not completed for thesis 
unc-32 V0, a-subunit e189 yes no effect 
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degeneration in the vha-12 mutant, the ADEs seem to be trending in the opposite 
direction towards more degeneration. Thus, when analyzing all head neurons 
together, any protection gained in CEPs is negated by the ADE value, result-
ing in a non-significant effect for total DA head neurons. 
A  
 
B 
 
C 
 
Figure 18 Effect of vha-12 (n2915sd) mutation in trp-4 (ot337) animals. Graphs in A show the 
mean DA neurons per class on top, and the mean total head DA neurons on the bottom. Non-
significant values are indicated by ‘ns.’ All significant values are indicated by *. Calculations were done 
with SEM. Multiple comparisons within the graphs were determined with Tukey’s test. Alpha was 0.05. 
Two-way ANOVA for the top graph and one-way ANOVA with the bottom graphs. The control strain 
vtIs1 (DA head neurons per worm=6, per category=2) was significant in all comparisons, but is omitted 
from these graphs. For vha-12 mutant, n=50 and trp-4(d) n=47. B shows a trp-4(d) worm C shows a 
vha-12;trp-4 double mutant. In both B and C, only ADE neurons are still present (compare to wild type 
on page XXX of this thesis). For both images, objective magnification is 40x, DIC on top and GFP MIP 
(maximum intensity projection) below. All figures generated from L4 animal data. Image credit, trp-4(d) 
worm: Dr. Doitsidou. 
 
Nonetheless, when considering CEPs versus ADEs it is conceivable that the dif-
ferent DA classes may vary in their susceptibility to protection as much as they 
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vary in their susceptibility to degeneration; with CEPs being more susceptible on 
both counts in comparison to ADEs- in this case. Of course, we also cannot rule 
out the possibility that there exist scoring errors. As with all of the results gener-
ated in this thesis, scorings will need to be performed at least three times, in a 
blinded way, with n>50 each time to confirm a suspected effect. 
 
 trp-4(d) de-
generation be-
gins at an early 
developmental 
stage. To de-
termine if the 
observed mild 
protection con-
ferred by the 
vha-12 mutation in CEPs in adult animals could be more pronounced in early 
stages, the scoring was repeated with L1 animals, Figure 19. No suppression 
was seen in L1 stage. It seems that the effects of vha-12 might be dependent on 
developmental stage. Scoring should be repeated for L1 through L4 to confirm 
the observed trends.  
Additionally, one could look at one through five-day-old adults and see if the mild 
protective effect in CEPs holds with advanced aging. Additional alleles of this 
gene could be tested for their effect on dopaminergic degeneration. However, as 
Ernstrom et al. reported, while the n2915sd allele is the weakest of the described 
vha-12 alleles, it is also viable.  Finally, this strain was not scored blindly in the 
L4s, but was in the L1s. A ‘blinded’ experiment gives more reliable results than 
an experiment where we are aware of the genotypes under investigation.  
 
Figure 19 L1 animals of vha-12(n2915sd) and trp-4 (ot337) double 
mutant did not experience any of the protection seen in L4 animals. No 
results were significant, except those with the control vtIs1 (****).  
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Further V-ATPase subunits were tested for involvement in trp-4(d) induced de-
generation; genetically in Figure 20 and with RNAi treatment in Figure 21.  vha-
3, unc-32, and vha-7 were chosen as genetic candidates to test. Figure 20A 
shows the results of the unc-32(e189) cross. e189 is a G to A transition and re-
sults in a partial loss-of-function mutation (Pujol et al., 2001). There was no sig-
nificant difference between any of the means, except with the control vtIs1 (not 
shown). Figure 20B shows the effects of a vha-3(ok1501) allele on trp-4(d) de-
generation. ok1501 is an allele from the C. elegans Gene Knockout Consortium. 
It results in a complex substitution of a 710 bp sequence with a 2 bp sequence 
that causes a frameshift. There was no effect in the CEPs with this mutant and 
also no effect on total head neurons. However, there was a protective effect in  
A  
 
B 
 
Figure 20 
V-ATPase subu-
nits further test-
ed for effects on 
trp-4(ot337) de-
generation.  A 
shows the scoring 
results for the unc-
32(e189) and trp-
4(ot337) double 
mutant. UNC-32 
encodes the a-
subunit in the V0 
Sector (membrane 
bound) of the V-
ATPase pump on 
the lysosome. 
e189 n=50, trp-4 
n=44 B shows the 
results for the vha-
3(ok1501) and trp-
4(ot337) double 
mutant. VHA-3 
encodes for the c 
subunit in the V0 
sector. All mutants 
were significantly 
different than the 
control vtIs1.  
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the ADE DA class. Crossing of vha-7 mutants was unsuccessful because of low 
mating efficiency and a lack of male availability, so this mutant could not be test-
ed. 
Since there was a protective trend in the vha-3 mutant with ADEs, and a protec-
tive trend in CEPs in the vha-12 mutant, it would be interesting to see if a double 
mutant between vha-12 and vha-3 would show a stronger or even synergistic ef-
fect. 
VHA-6, VHA-10, VHA-11, and VHA-17 were additionally tested through RNAi, 
Figure 21. In Figure 21A the VHA-17 and VHA-11 RNAi treatments are shown 
along with control RNAi treatments CRT-1 (which was previously shown with mu-
tants and RNAi to suppress trp-4(d) degeneration (Nagarajan et al., 2014)) and 
empty vector. Though there seems to be suppression with VHA-11 and VHA-17, 
it cannot be determined if this effect implies involvement.  This round of treat-
ments did not pass its controls; the positive control, CRT-1 RNAi, normally sup-
presses trp-4(d) degeneration in dopaminergic neurons and was not significantly 
different from empty vector in this case. This can be due to many variables, in-
cluding, but not limited to: plate freshness, IPTG quality, and a clean culture of 
 
A
 
 
B 
 
 
C 
 
Figure 21 RNA Interference on V-ATPase Pump Subunits Subunits in both the A and C V1 
(A, VHA-11 and C, VHA-10 ) and A and B V0 (A, VHA-17 and B, VHA-6) sectors were tested. 
In B and C, both VHA RNAi treatments were worse than CRT-1 treatment and ns with empty 
vector, so the DA class graph is not shown. A  vha-11 n=45, vha-17 n=41, crt-1 n=44, and 
empty vector n=49 B vha-10 n=53, crt-1 n=48, and empty vector n=41 C vha-6 n=50, crt-1 
n=50, and empty vector n=48. 
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each RNAi clone. This experiment will need to be repeated to see if the protec-
tion with can be reproduced. The VHA-4 RNAi proved to be lethal and could not 
be overcome by performing RNAi on L4 (instead of younger) worms and scoring 
their progeny. Figure 21B and C show the VHA-10 and VHA-6 RNAi treatments. 
The controls for both were passed. In both cases, crt-1 RNAi treatment partially 
suppressed degeneration. However, none of the two were different from the 
empty vector.  
Only three of the V-ATPase pump genes have reported expression patterns in 
neurons (vha-12, vha-10, and vha-2), but one of the genes for which we ob-
served a protective trend, vha-3, does not. In choosing genes to test, we did not 
exclude genes solely on the basis of their lack of reported expression in the 
nervous system as reported expression pattern can be incomplete.  
Pharmacological Approach 
Although in previous studies on the mec-4(d) model of degeneration it was pos-
sible to observe protective effects through single-gene knockdowns, it is not clear 
to what degree the genes coding for the V-ATPase pump subunits are redundant. 
Thus, eliminating or compromising one of the factors genetically may not block 
the function of pump. In contrast, chemical inhibition bypasses redundancy is-
sues and thus can be more effective. We used the chemical bafilomycin, which  
inhibits the pump. With this chemical, acidification of the lysosome is compro-
A 
 
Figure 22 Effect of Bafilomycin A1 trp-4(d) neurodegeneration is shown for the individual DA clas-
ses on the left and for total head neurons on the right. Bafilomycin treated trp-4 n=57 and DMSO 
treated trp-4 n=94 
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mised and degradation of lysosomal contents does not properly occur; both con-
sequences of V-ATPAse pump inhibition by bafilomycin (Yoshimori 1991). 
Bafilomycin A1 (50 μM, Sigma) was injected into the body cavity of gravid her-
maphrodites (Syntichaki et al., 2005), and DMSO with nuclease-free water was 
injected into control animals. Progeny of injected hermaphrodites were scored at 
L4 stage. Figure 22A shows the results of the scoring. There was no significant 
effect with this treatment. 
In order to determine if the lack of effect meant a lack of involvement of the 
pump- or rather a failure in delivery of the chemical- mec-4::GFP;mec-4(u231) 
animals were similarly injected as a positive control. Due to low numbers of the 
population scored, the control was not conclusive to determine if the treatment 
was effective or not.  
Injecting the chemical directly in the body cavity was previously used to success-
fully inhibit the pump in the mec-4(d) model. It seems that the bafilomycin chemi-
cal is capable of penetrating across gonadal tissue. In order to have any effect on 
the embryos, it must also be capable of penetrating the eggshell as well as the 
embryonic sheath at later stages (Altun, 2009). Alternatively, one could soak the 
embryos in the chemical, though the chemical is harmful and thus this would 
need to undergo a concentration range to determine the best concentration and 
time at which to perform the experiment. Finally, it is necessary to perform the 
method in a way as to reproduce previous results in the mec-4(d) model. When 
optimization has been performed and the method is capable of reproducing past 
result- then reliable results can be produced for this experiment and conclusions 
regarding the V-ATPase pump can be drawn. 
Previous experiments explored the roles of calpain and aspartyl proteases in the 
trp-4(d) model (Bachelor’s Thesis, Maugard, 2013). Unlike results with the mec-
4(d) channel, genetic manipulation of these factors did not yield significant neu-
roprotective or cytotoxic effects. Both pathways, the activation of proteases and 
the V-ATPase pump, are thought to be involved in lysosomal acidification and 
rupture. As such, both have been shown to be effectors of necrotic cell death 
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suppression (Syntichaki et al., 2002) (Syntichaki et al., 2005).  Even if these fac-
tors indeed play a role in trp-4(d) mediated degeneration, it is possible that the 
hyperactivated Trp-4(d) channel is too cytotoxic or acts too acutely for mild pro-
tection to be discernable. Yet, it was shown previously that it is possible to signif-
icantly suppress dopaminergic degeneration in the trp-4(d) model, for example 
with intracellular Ca++ manipulations (Nagarajan et al., 2014). Thus, there exist 
pathways through which one can interfere with such acute neuronal insult. It re-
mains to be seen if lysosomal acidification is one of these pathways, and to what 
degree it is involved in trp-4(d) cell death. To this end, the question of redundan-
cy needs to be addressed; both the proteases and the pump genes have been 
explored, but have been done so with single-gene-knockdowns. Double mutants 
or double RNAi treatments could be the key for potent protection of dopaminergic 
neurons. 
Lysosomal biogenesis 
Artal-Sanz et al. showed that mutations in the lysosomal biogenesis pathway led 
to suppression of mec-4(d) induced degeneration; the group found that mutations 
impairing lysosomal biogenesis suppressed death whereas those that increased 
biogenesis increased death. To test if lysosomal biogenesis is involved in trp-4(d) 
induced degeneration, the glo-1(zu391) gene was crossed with the trp-4 mutant, 
Figure 23. One allele of the glo-1 gene (zu391) was tested in this thesis (Figure 
23A) and was found to partially suppress trp-4(d) degeneration throughout all DA 
classes and had a significant effect when all head neurons were considered. The 
protective effect provided by the glo-1 mutant is not complete Figure 23D when 
compared to trp-4(d) Figure 23C, but significant.  
Expression patterns have localized GLO-1 to the gut (Hermann et al., 2005). Yet, 
it seems to have an effect in the DA system. There are two main possibilities 
here. The first is that glo-1 is expressed in dopamine neurons. Alternatively, if 
GLO-1 is indeed gut-specific, then it is possible that there is a cell non-
autonomous effect. This can be tested by tissue-specific rescue experiments.  
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Finally, it will be necessary to test more glo-1 alleles, and additional lysosomal 
biogenesis pathway mutants, for example the other glo genes. 
A 
 
B 
 
C 
 
 
Figure 23 Effect of Lysosomal Biogenesis on trp-4(ot337) degeneration. Scoring data for allele in-
volved in lysosomal biogenesis seen in A  (glo-1 n=44, trp-4 n=51) The trp-4(d) mutant is seen in B, and 
the double mutant with glo-1(zu391) is seen in C. trp-4(d) image credit to Maria Doitsidou. 
Lysosomal Reporter 
The lysosomes in the mec-4(d) model exhibited perinuclear clustering as well as 
enlargement and ultimately loss of lysosomes, most likely through rupture (Artal-
Sanz et al., 2006). To determine if these events also transpired in the trp-4(d) 
model, a lysosomal reporter needed to be generated in the DA neurons. To this 
end, the commonly used LMP-1::GFP reporter was expressed under a DAT-1 
promoter, Figure 24. Lysosomes are clearly and specifically marked by this re-
porter and one can even observe dynamic transport events happening in real 
time. When the neuronal projections are observed, marked vesicles can be seen 
in the axons.  
 
57 
 
  
  This reporter was crossed into the trp-4(d) mutant Figure 25. Lysosomal mor-
phology was observed for differences with the wild type. In Figure 25A we can 
see the entire head of an L1 organism. A GFP MIP is shown to visualize the 
head in one plane. The interrupted projections in this head can be contrasted 
with the neat projections in Figure 24. Below the head are three panels of the 
CEPs in this animal. The panels are in descending order of health/viability. In 
Figure 25B we can see a relatively healthy CEPD- though already exhibiting 
signs of perinuclear clustering. There are many lysosomes and they are small. 
The cell is not swollen and its projection is intact. In Figure 25C a CEPV in the 
process of dying is seen. The cell is rounded and its projection has begun to 
A 
 
B 
 
Figure 24 LMP-1::GFP under a DAT-1 Promoter. In A, the different DA classes 
are marked by colored arrows. From anterior to posterior: CEPVs: purple, 
CEPDs: blue, and ADEs: yellow. Image was taken at 40x objective. B shows a 
panel of left to right: DIC, GFP, and a merged image at 30% transparency. Image 
taken at 100x objective. 
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clear. The lysosomes seem to be fewer than in the healthier CEPD. We can see 
what appears to be enlarged lysosomes in the path of the dying projection. There 
is clear perinuclear clustering when the merged panel is considered. Finally, in 
Figure 25D, we can see a cell that is fading away. It is grossly enlarged in com-
parison to the other CEPs. Its projection is dotted and completely separated from 
the cell. The lysosome in this figure is enlarged and is singular. This may mean 
that a fusion of lysosomes has occurred, and one large lysosome in the end has 
been formed as a result. It also has migrated to the periphery of the nucleus. One 
CEPV has already died and been cleared- or if not entirely cleared then the LMP-
1 proteins have been cleared. 
These are initial observations and have yet to be quantified. Yet, they give us in-
sight into the nature of cell death in the trp-4(d) model. In the mec-4(d) model, 
the lysosomes exhibit signs of perinuclear clustering and rupture (Artal-Sanz et 
al., 2006). Here, we can certainly see perinuclear clustering, however, lysosomal 
rupture has not been observed. The kinetics of the death cannot be ignored- this 
is a swift process. Thus, many more images or a time lapse will need to be gen-
erated in order to clarify the death events in this model. 
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Additionally, crosses with suppressors of trp-4(d) degeneration can be completed, 
and further observations into the consequences of these suppressors to lysoso-
mal morphology can be made. All of these morphological observations will pro-
vide insight into the subcellular events of trp-4(d) cell death. 
In summary, the lysosomal acidification through V-ATPase pump, HS precondi-
tioning, and lysosomal biogenesis were tested as candidate pathways for their 
involvement in trp-4(d) degeneration. All three of these candidates had success-
fully conferred protective effects in other models of neurodegeneration. Out of 
these three, lysosomal biogenesis has been uncovered as a potentially protective 
pathway in the trp-4(d) model and tools were generated for visualization of the 
lysosome in dopaminergic neurons. Protective trends in the other two explored 
pathways were also observed, which need further investigation.  
HS preconditioning 
It was previously reported that Heat Shock (HS) preconditioning protects the 
mechanosensory neurons from necrotic degeneration (Kourtis et al., 2012). To 
test whether such a protective effect can be seen for dopaminergic neurons in 
trp-4(d) mutant HS preconditioning will be referred to as simply HS, though this 
should not be confused with a true HS treatment, which is conducted at 39º as 
outlined by Kourtis et 
al.  
Two separate experi-
mental strategies 
were followed for ex-
posure to heat, which 
are reflected in the 
Figure 25 LMP-1::GFP in a trp-4(d) mutant is shown here. A shows the MIP of the GFP in the head. B 
shows a CEPD (blue uppermost arrow in A), C shows a CEPV (purple arrow), and D shows a CEPD (blue 
lower arrow in A).  All images were taken at 100x of L1 organisms. 
A 
 
Figure 26 Effect of HS preconditioning on trp-4(d) neurodegenera-
tion was completed two times, once on 18/4/2014 (left) and once on 
9/6/2014 (right). For 18/4:  At 20°, n=49; At 34°, n=46. For 9/6:  At 20°, 
n=33, At 34°, n=42 
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two scoring events in Figure 26. The first, strictly followed the protocol described 
in (Kourtis et al., 2012). In the second, the worms were left to nutate for one hour 
after the HS treatment to avoid developmental defects caused by the application 
of moderate heat at early embryonic stages. The two different methods resulted 
in two different trends, with a toxic effect seen in the first case, when the heat 
was applied too early, and a protective trend seen in the second. For all scorings, 
L1 animals were observed. 
The experiment, following the first method, was also performed on mec-4(d) mu-
tants as a positive control. In published results, there is a 66.7% decrease in cell 
corpses between the 20º and 34º treatments. While seeing a clear protective ef-
fect, not enough data were generated to be able to reliable use the mec-4d mod-
el as a positive control of our experimental conditions. The developmental and 
degeneration dynamics in the mec-4(d) model differ from the trp-4(d); familiarity 
with the mec-4(d) model could allow a proper comparison between the two mod-
els.  
The first trp-4(d) scoring was completed with more individuals (At 20°, n=49; At 
34°, n=46), thus the statistics that are performed on this data set provide more 
reliability than the other scoring event (At 20°, n=33: At 34°, n=42). Since there 
exist such variance between the two events, it is best to perform another round of 
experimentation with more individuals (n~100 for both temperatures) than to re-
flect deeply on either of these data sets.  
Unbiased Approach 
In addition to the more classical candidate approach, an unbiased approach was 
employed to discover novel mutations affecting trp-4(d) cell death. A screen for 
suppression of degeneration was chosen as the discovery method, and EMS 
was utilized as the mutagen. During four rounds of automated screening, three 
full suppressors and three partial suppressors were discovered in a screen, Ta-
ble 5. The screening strain, norSci1_[dat1::Trp-4(d)_unc-119]II; unc-119(ed3)III; 
trp- 
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 4(ot337)I;vtIs128, was developed after previous screens had failed to yield sup-
pressors with intergenic mutations- mutations that did not occur on the trp-4 lo-
cus itself. This strain has two copies of the mutated trp-4(d) gene: one endoge-
nous copy and one Mosci single-copy insertion. The strategy behind using this 
strain was to reduce the probability of intragenic mutations. Though they would 
still happen, it is more probable that they would occur on one of the copies, but 
not both. This remained a possibility, just a less probable one.   
Suspected full suppressors were confirmed to be intergenic by crossing to a wild 
type strain. A red fluorescent reporter (otIs356[rab-3::NLS::tagRFP]V) in the wild 
type strain was employed to distinguish cross progeny. The F1 generation was  
 
observed for degeneration. If degeneration was observed, we concluded that the 
mutant was a non-intragenic, recessive full suppressor and if none was observed, 
cross-progeny individuals were singled. If their progeny did not exhibit degenera-
28 This was built by Mosci insertion by a post-doc in the lab, Janete Chung. 
Table 5 Mutants isolated during the thesis are listed in this table. Historic, classification names are 
indicated at the end of the genotype. The screening strain for all of these was: norSci1_[dat1::Trp-
4(d)_unc-119]II; unc-119(ed3)III; trp-4(ot337)I;vtIs1. Until WGS results are retuned, their molecular identi-
ty will remain unknown. 
Strain Genotype Phenotype 
MDH236 nor4;norSci1_[dat1::Trp-4(d)_unc-119]II;unc-
119(ed3)III; trp-4(ot337)I;vtIs1V(2.6.2.3) 
Full suppressor  
MDH237 nor5;norSci1_[dat1::Trp-4(d)_unc-119]II;unc-
119(ed3)III;trp-4(ot337)I;vtIs1V(2.12.3.1) 
Full suppressor  
MDH238  nor6;norSci1_[dat1::Trp-4(d)_unc-119]II;unc-
119(ed3)III;trp-4(ot337)I;vtIs1V(2.7) 
Full suppressor 
MDH239  nor7;norSci1_[dat1::Trp-4(d)_unc-119]II;unc-
119(ed3)III;trp-4(ot337)I;vtIs1V(1.5.6) 
Partial suppressor in CEPs 
MDH263 nor11;norSci1_[dat1::Trp-4(d)_unc-119]II;unc-
119(ed3)III;trp-4(ot337)I;vtIs1V(3c41) 
Partial suppressor in DA classes 
MDH264 nor12;norSci1_[dat1::Trp-4(d)_unc-119]II;unc-
119(ed3)III;trp-4(ot337)I;vtIs1V(35b) 
Partial suppressor in ADEs 
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tion, the mutation was deemed intragenic, if it did, it was declared a dominant 
non-intragenic suppressor.  
All six retrieved suppressors, Figure 27, were confirmed to be intergenic by 
crossing to a wild type strain. (as described above an in Materials and Methods 
section) Additionally, it was determined using standard genetic crosses with re-
porters on known chromo-
somes that the causative mu-
tation most likely rests on 
chromosome III. Notably, 
none of the genetic suppres-
sors for trp-4(d) reported so 
far in this thesis and in Naga-
rajan et al.  lie on chromo-
some III. 
The full suppressors were 
sent out for whole genome 
sequencing. Upon the sub-
mission of this thesis, se-
quencing results are yet una-
vailable. When results are ob-
tained, those mutations on 
chromosome III will be re-
viewed and tested. Analysis 
and characterization will be 
continued with the identifica-
tion of the causative muta-
tions in the full suppressors.   
A 
 
B 
 
C 
 
Figure 27 Partial Suppressors from EMS screens were 
(with their historic names): A: 1.5.6, B: 35B, and C: 3C41. 
Two-tailed unpaired t-test with Welch’s correction deter-
mined significant for the Total DA Neurons graphs.  
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Conclusions & Future Directions 
This thesis explored three pathways previously implicated in necrotic cell death in 
mechanosensory neurons, for their involvement in the degeneration of dopamine 
neurons in the trp-4(d) model. It also detailed the building of a new reporter, 
which will add morphological insight into trp-4(d) cell death. Finally, six suppres-
sor mutants were isolated that will contribute to a novel understanding of trp-4(d) 
cell death. 
Lysosomal acidification through V-ATPase Pump 
The results gathered in this thesis, are not conclusive as to whether or not the V-
ATPase pump plays a role in trp-4(d) degeneration. A protective trend when 
knocking down some subunits was observed (VHA-12, 3, 11 and 17), however 
more experiments are required. In order to determine if cellular acidification is a 
factor in trp-4(d) induced degeneration, it would be very useful to track the neu-
ronal pH with pH sensitive reporters. Moreover, although knocking down single 
subunits of the V-ATPase pump has not yielded thus far strong suppression, by 
building double mutants with vha genes more than mild protection may be seen. 
If the vha-12 and vha-3 mutations are proven protective through more scorings, it 
would be interesting to know whether this effect is because of its role in lysoso-
mal acidification or via a different mechanism. 
Further pursuing the pharmacological approach can give a more determinate an-
swer as to the involvement of the pump. For this, the Bafilomycin protocol needs 
to be optimized in order to determine the most effective means of treatment for 
the heavily-protected embryos.  
Lysosomal Biogenesis 
Interference with GLO-1 function has resulted in a suppression in trp-4(d) cell 
death.  This result points to an involvement of the lysosomal biogenesis path-
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ways in our cell death model. Expression of glo-1 has been reported to only be in 
the intestine. However, this is not certain, as in the publication images (Hermann 
et al., 2005) only the intestine is visible in the adult DIC image. Moreover, it is 
possible that its expression is highest in the gut and minimal enough in DA neu-
rons to have gone unnoticed- a phenotype can only be known once it is looked 
for. The question remains as to whether or not glo-1 is expressed in dopaminer-
gic neurons in C. elegans. If it is not, than either this result is an artefact of the 
strain we used or the suppression is the result of a cell- non-autonomous path-
way. In order to address the former question another allele of glo-1 should be 
scored in trp-4(d) mutants. To address the latter question, cell specific rescue 
can be performed, by expressing glo-1 specifically in the dopaminergic neurons 
and complementary cell specific rescue in other tissues.  
Additionally, the glo-1 mutant should be crossed with the LMP-1::GFP reporter to 
determine if the lysosomal morphology is affected in trp-4(d) mutants and how it 
is different, if at all, in glo-1;trp-4 mutants. glo-1 was discovered as defective in 
gut granule biogenesis. Should the DA neurons indeed contain similar LRO, this 
would also implicate DA neurons in C. elegans to be a melanosome like cell- 
containing a pigment molecule (Coburn and Gems, 2013) (Raposo and Marks, 
2007). The birefringent matter in the gut granules is a kynurenine pathway prod-
uct and kynurenine pathway dysregulation has been implicated in many neuro-
degenerative diseases as well as acute insults (Vecsei et al., 2013) (Stone et al., 
2012). 
cup-5 mutants should also be crossed with trp-4(d) mutants to explore whether 
they will have the opposite effect to the glo-1 mutants. While glo-1 mutants impair 
lysosomal biogenesis, cup-5 mutants promote the formation of lysosomes and 
thus exacerbate necrosis in the mec-4(d) model (Artal-Sanz et al., 2006). 
HS Preconditioning 
Further experiments are required to determine whether induction of stress re-
sponses, like the heat shock response induced after preconditioning, is protective 
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to neuronal cell death in the trp-4(d) model. The HS preconditioning method 
needs to be improved, and potentially other stress response pathways can be 
explored.  
Forward Genetic Screen 
Undertaking an unbiased approach, three partial and three full suppressors of 
trp-4(d) cell death were discovered in the course of this thesis. The partial sup-
pressors come from two rounds of screening and the full suppressors come from 
one round. Given the rarity of any suppression experienced in previously con-
ducted screens, three unique full suppressors would be extraordinary based on 
the P0 population (Less than the recommended in Figure 15A). It is most likely 
that these are siblings. However, even one true full suppressor will provide great 
insight into the mechanism of trp-4(d) mediated neurodegeneration. Moreover, 
the three partial suppressors could also potential uncover novel players in this 
pathway. 
The TRP-4d Model 
The TRP-4d model of cell death could potentially be an important one in studies 
of neurodegeneration. It shares many features with existing models, such as its 
necrotic presentation and its resemblance to excitotoxic death. Yet, it is distinct in 
others, like its progressive manifestation. The implication of the lysosome in its 
mechanisms additionally makes it an attractive model for neurodegenerative 
studies- as this is a topic undergoing much research. The fact that TRP-4d de-
generation affects dopaminergic neurons opens two perspectives. The first of 
which is that this model can be used to identify DA-specific ways to suppress de-
generation. Furthermore, it would be interesting whether polymorphisms in hu-
man TRP channels are associated with PD.  
In order to implicate the TRP-4d model as an important in cell death pathways, 
more characterization is necessary. Events in cell death pathways are not ran-
dom, as demonstrated by many models. The use of microfluidics, nano-beads, or 
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other means of constant monitoring of one worm over a period of time is neces-
sary to describe the intracellular degeneration dynamics in order to further estab-
lish the trp-4 model and its use in neurodegeneration studies.  
It would be useful to determine the basal slowing response in L1 organisms. As 
this is when the degeneration is proposed to begin. In addition, lifespan of trp-4 
mutants is not established and should be to provide a baseline for aging studies. 
Assuming that TRP-4d is a very “aggressive” channel, one could cross the sup-
pressed degeneration mutant crt-1;trp-4 with any of the most promising of the 
candidates tested here. Thus, any mild suppression that would have been ruled 
insignificant otherwise, could manifest, and possibly yield a synergistic effect.  
Localization of the trp-4 channel should also be determined. It was previously 
shown to be located on the cell membrane; Is it also located on the membrane of 
an organelle, or possibly many organelles? Does such localization contribute to 
the observed neuronal damage? 
As with most research projects, this thesis began with a set of questions and has 
ended with new questions. The lysosome has been implicated in trp-4(d) degen-
eration, and this relationship should be further probed and explored. 
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Appendix 
Crossing Schemes 
1 General cross 
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2 Cross involving the X chromosome 
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Primers 
Under the primer sequences is the predicated molecular characterization. After 
TP73, the oligo calculator on the IDT technologies website was used. Only pri-
mers used in this thesis are included, so there are gaps in the numbering. 
 
# F/R GENE/Restriction^Site/nucleotides Name/Use Notes 
TP35 F TTGATCAGCTGGAACGAGAA 
 
VHA-7, OK1952 
external 
NCBI: 
WT: 2747 
MUT: 998 56.87 45.00  
 
TP36 R GAACTGTAGCCGGTGGGAAT 
 
59.75 55.00  
 
TP37 F AAGTTCCAAGGATGAGGGCG 
 
Vha-3, 
ok1501external  
NCBI: 
Wt: 1359 
MUT: 652 60.04 55.00  
 
 
TP38 R AGTCGCAGGAAATGCTCGAA 
 
60.04 50.00  
 
TP39 F CAGACGCAGTAAGAAACGGC 
 
Vha-12, ok821 
external 
 
NCBI 
 
Wt: 1518 
MUT: 373 
59.56 55.00  
 
TP40 R ACGTAGATCTGTCCCTCGGT 
 
59.74 55.00  
 
TP41 F CGTTCCGGACAGGTTCTTGA 
 
VHA-12, OK821 
INTERNAL 
NCBI 
 
WT:260 
MUT:0 
59.97 55.00  
 
TP42 R CCAAGAAGTCCTCGGCAAGT 
 
59.96 55.00  
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TP43 F TTTGTCGCCGGAGTTCTACC 
 
Vha-7, ok1952 
INTERNAL 
Ncbi 
Wt: 271 
Mut: 0 60.04 55.00  
 
TP44 R AGCGGATTTTTCTCACCCGT 
 
59.96 50.00  
 
TP45 F TCGTGGCTATGGTTCTCAAGG 
 
VHA-2, OK619 
EXTERNAL 
Ncbi: 
Wt: 1827 
Mut: 885 59.79 52.38  
 
TP46 R GCAGTGCAGGTGGTAAAAGC 
 
60.04 55.00  
 
TP47 F TCTTTCGGCGGTTTCCAAGT 
 
VHA-3, OK1501 
INTERNAL 
Ncbi: 
Wt: 459 
Mut: 0 60.18 50.00  
 
TP48 R CGCAATAGTTCGTCACGGTC 
 
59.36 55.00  
 
TP49 F ACGACGACTTGTCTCCGTTT VHA-2, OK619 
INTERNAL 
Ncbi: 
Wt: 372 
Mut: 0 
 
TP50 R CATACCTGTTCTCCCGTGGC 
 
TP54 
 
R GAAACTCGATGGATATTTTTGCAAAAGCT 
 
TP57 F TATTGACCACCTTGTTCAGTGGAGAGTAC DCAPS, glo-1 
zu391 (2 mis-
mmatches) 
 
ATCACT-
>>AGT*ACT 
(ScaI) 
 
 
TP58 R ACAAAGCGATGAAATCCCTCTCA 
 
TP59 F tcatcggaatgacagacttgg Glo-1 zu391 ex-
ternal primer 
 
 
TP60 F taccgttttggcaacattccg Lmp-1 externals 
 
 
From Andrew fire paper 
(lmp-1 discovery)  
TP61 R ggcaaaccaaggtaattcaacaacc 
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TP62 F AGACTTGGTCAGTTGGGAAAACGGTGC INTERNAL LMP-1 
 
TP63 R gttttcgctacacgtaggctgaatgc EXTERNAL LMP-
1  
Tm: 58 
TP64 F ttggagGGTACCATGTTGAAATCGTTTGTCATCTTG FOR CLONING- 
introduces KPNI 
at N-terminus of 
lmp-1 
 
Tm: 60 
TP65 R gttgGAATTCCTATTTGTATAGTTCATCCATGC For cloning- intro-
duces ECORI site 
at COOH of GFP 
Tm: 58 
TP66 F tcagGGATCCATGTTGAAATCGTTTGTCATCTTG Cloning strategy 
2- introduces 
BAMHI at NH3 of 
lmp-1  
 
 
62 
TP67 R CTACCGGTACCAAGACGCTGGCATATCCTTGTC Cloning strategy 
2-introduces KPNI 
at COOH of lmp-1 
62 
TP68     
 
TP69 F GCTTGTTGTCTTGACCGACA Primers for vha-12  
 
TP70 R CTAGTACCTTGGGTGATGAAG 
TP71 F GAGACGGATCAATCACACAAA Reverse primer is 
DCAPS  
 
These will geno-
type vha-12 
(n2915sd) 
 
 
 
 
 
 
 
 
 
TP72 R 
 
 
GATCTTCTCTTGTCATTCCTTCTCTTATA 
TP76 F AGA TGT CCA GGC GAT GAA GG 
 
TP77 F GTC TTG TTC GTA TCC TTC TCC UNC-32 (E189) 
SNP 
 
Reverse primer is 
DCAPS 
 
Cuts mutant with 
DCAPS program, me 
 
TP78 R GGTGGCAACATTTCTCCAGTCCCAGC 
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AluI 
TP79 R atacaacgacgagtaggagc For e189, after 
DCAPS, can be 
used with TP77 
for sequencing 
Product: 356 
 
   
 
TP 
80 
F ATCCTGTGACAGTTCTCTCG  For apb-3(ok492) External 
MUT:411 
WT:1477 
 
TP81 R GCATCCATTATTTGACGACTT 
 
TP82 R CGTTCCTTGAAACTACTAATAA For apb-3(ok492) Internal 
Mut:0 
Wt:562 
 
TP83 F AAGAAGAGGATGATAGTGAGC 
 
TP84 F TTTGAACGCCTCCTCAATGC For glo-1 (zu439) 
This mutation 
changes trp-
106  into a stop 
codon 
 
 
TP85 R ACACATTGATCACAGTGTGC 
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